(1,4,5-trisubstituted-1H-pyrazol-3-yl)oxy-2-alkoxythioalkyl acids and derivatives thereof, their salts and their use as herbicidal active agents

Novel (1,4,5-trisubstituted 1H-pyrazol-3-yl)oxy-2-alkylthioalkyl acids provide effective and selective herbicidal action against weeds while protecting crop plants, addressing the limitations of existing herbicides.

JP2024542693AInactive Publication Date: 2024-11-15BAYER AG
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
JP2024532461
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-01
Filing Date
2022-11-28
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing herbicides lack effectiveness against a wide range of harmful plants and do not provide sufficient selectivity for use in crop plants, leading to potential damage to desirable vegetation.

Method used

Development of novel (1,4,5-trisubstituted 1H-pyrazol-3-yl)oxy-2-alkylthioalkyl acids and their derivatives, which exhibit strong herbicidal action with high selectivity, allowing for targeted control of broad-leaved weeds and grasses without harming crop plants.

Benefits of technology

These compounds demonstrate excellent herbicidal efficacy against a broad spectrum of weeds while maintaining compatibility with crop plants, enabling selective application in agricultural settings.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024542693000001_ABST
    Figure 2024542693000001_ABST
Patent Text Reader

Abstract

The present invention relates to novel herbicidally active (1,4,5-trisubstituted-1H-pyrazol-3-yl)oxy-2-alkoxyalkyl acids and derivatives thereof according to general formula (I), their agrochemically compatible / acceptable salts, N-oxides, hydrates and the hydrates of the salts and N-oxides, their process for the preparation and their use for the control of weeds and grass weeds in crops and for the general control of weeds and grass weeds in areas of the environment where plant growth is undesirable. The derivatives of (1,4,5-trisubstituted-1H-pyrazol-3-yl)oxy-2-alkoxyalkyl acids include in particular their esters and / or amides. [Case 1] TIFF2024542693000111.tif6061
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] explanation The present invention relates to novel herbicidally active (1,4,5-trisubstituted 1H-pyrazol-3-yl)oxy-2-alkylthioalkyl acids of general formula (I) and derivatives thereof, their agriculturally compatible / acceptable salts, N-oxides, hydrates and hydrates of the salts and N-oxides, processes for their preparation and their use for the control of broadleaf and weed grasses in crops of useful plants and for the general control of broadleaf and weed grasses in areas of the environment where plant growth is problematic. [Background technology]

[0002] Derivatives of (1,4,5-trisubstituted 1H-pyrazol-3-yl)oxy-2-alkylthioalkyl acids include in particular the esters, acids, salts and / or amides thereof.

[0003] The prior art discloses the biological effects of substituted 1,5-diphenylpyrazolyl-3-oxoacetic acids and methods for the preparation of these compounds.DE 2828529 A1 describes the preparation and hypolipidemic activity of 1,5-diphenylpyrazolyl-3-oxoacids.

[0004] CN101284815 discloses 1,5-diphenylpyrazolyl-3-oxoacetic acid as a fungicidal pesticide. Journal of Heterocyclic Chemistry (2012), 49(6), 1370-1375 describes the further synthesis and fungicidal activity of 1,5-diphenylpyrazolyl-3-oxoacetic acid.

[0005] WO2008 / 083233A2 describes 1,5-diphenylpyrazolyl-3-oxyalkyl acids and their derivatives substituted at the 4-position of pyrazole as substances suitable for breaking down cell aggregates. Ethyl [(4-chloro-1,5-diphenyl-1H-pyrazol-3-yl)oxy]acetate is specifically disclosed.

[0006] WO2020 / 245044A1 describes substituted 1-phenyl-5-azinylpyrazolyl-3-oxyalkyl acids and their derivatives as herbicidal substances. WO2021 / 122728A1 discloses 1-phenyl-5-thienylpyrazolyl-3-oxyalkyl acids and 1,5-diphenylpyrazolyl-3-oxyalkyl acids substituted at the 4-position of the pyrazole and having herbicidal activity.

[0007] Furthermore, the synthesis of some 4-chloro-1,5-diphenylpyrazolyl-3-oxyacetic acids and their ethyl esters is described in the European Journal of Organic Chemistry (2011), 2011(27), 5323-5330.

[0008] The (1,4,5-trisubstituted 1H-pyrazol-3-yl)oxy-2-alkylthioalkyl acids and derivatives of the present invention are 2 It differs from the already known 1,5-diarylpyrazolyl-3-oxoacetic acids by the radical =(C1-C4)-alkylthio. [Prior art documents] [Patent documents]

[0009] [Patent Document 1] DE 2828529 A1 [Patent Document 2] China Patent Application Publication No. 101284815 [Patent Document 3] International Publication No. 2008 / 083233 [Patent Document 4] International Publication No. 2020 / 245044 [Patent Document 5] International Publication No. 2021 / 122728 [Non-patent literature]

[0010] [Non-Patent Document 1] Journal of Heterocyclic Chemistry(2012), 49(6), 1370-1375 [Non-Patent Document 2] European Journal of Organic Chemistry(2011), 2011(27), 5323-5330 Summary of the Invention [Problem to be solved by the invention]

[0011] The object of the present invention is to provide novel pyrazole derivatives, i.e., (1,4,5-trisubstituted 1H-pyrazol-3-yl)oxy-2-alkylthioalkyl acids and derivatives thereof, which have good herbicidal activity and efficacy against a wide range of harmful plants and can be used as herbicides or plant growth regulators. [Means for solving the problem]

[0012] The object of this invention is to provide a method for the preparation of (1,4,5-trisubstituted 1H-pyrazol-3-yl)oxy-2-alkylthioalkyl acids, in which the substituents R 2 is (C1-C4)-alkylthio), which is characterized by a very good herbicidal action and also has very good selectivity.

[0013] Surprisingly, these compounds are highly effective against a wide range of economically important grass weeds and broadleaf weeds.At the same time, the compounds show good crop plant compatibility.Therefore, considering their good effectiveness against harmful plants, they can be selectively used in crop plants.

[0014] Thus, the present invention relates to a compound of general formula (I) [ka] [During the ceremony, A is selected from the group consisting of A1, A2 and A3; [ka] Q is selected from the group consisting of Q1 to Q16; [ka] R 1 OR 1a or NR 9 R 10 and R 1a is hydrogen, or (C1-C6)-alkyl or (C3-C6)-cycloalkyl, which are unsubstituted or each independently COOR 5 , substituted by "m" radicals selected from the group consisting of halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C3-C6)-cycloalkyl, (C1-C6)-alkoxy, cyano and nitro, or (C3-C4)-alkenyl or (C3-C4)-alkynyl, or (C1-C6)-alkyl-S-(C1-C6)-alkyl-, (C1-C6)-alkyl-SO-(C1-C6)-alkyl- or (C1-C6)-alkyl-SO2-(C1-C6)-alkyl-, or heterocyclyl, heteroaryl or aryl, or heterocyclyl-(C1-C4)-alkyl-, heteroaryl-(C1-C4)-alkyl- or aryl-(C1-C4)-alkyl-, which are unsubstituted or substituted by "m" radicals, each independently selected from the group consisting of halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl; R 9 is hydrogen or (C1-C 12 )-alkyl, R 10 is hydrogen, aryl, heteroaryl, heterocyclyl, (C1-C 12)-alkyl, (C3-C8)-cycloalkyl, (C3-C8)-cycloalkyl-(C1-C7)-alkyl-, (C2-C 12 )-alkenyl, (C5-C7)-cycloalkenyl, (C2-C 12 )-Alkynyl, S(O) n R 5 , Cyano, OR 5 , SO2NR 6 R 7 , CO2R 8 or COR 8 wherein the above alkyl, cycloalkyl, alkenyl, cycloalkenyl and alkynyl radicals are unsubstituted or each independently may be mono- or polysubstituted aryl, halogen, cyano, nitro, OR 5 , S(O) n R 5 , SO2NR 6 R 7 , CO2R 8 ,CONR 6 R 8 , C.O.R. 6 , N.R. 6 R 8 , N.R. 6 COR 8 , N.R. 6 CONR 8 R 8 , N.R. 6 CO2R 8 , N.R. 6 SO2R 8 , N.R. 6 SO2NR 6 R 8 , C(R 6 )=NOR 8 and is substituted with "m" radicals selected from the group consisting of: or R 9 and R 10 taken together with the nitrogen atom to which they are attached, represent halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, OR 5 , S(O) n R 5 , CO2R 8 ,CONR 6 R 8, C.O.R. 6 and C(R 6 )=NOR 8 and, in addition to the nitrogen atom, the ring atoms include "r" carbon atoms, "o" oxygen atoms, "p" sulfur atoms, and NR 7 , CO and NCOR 7 forming a saturated or partially or fully unsaturated 5-, 6- or 7-membered ring containing "q" elements from the group consisting of: R 5 is (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C1-C6)-haloalkyl or aryl, R 6 is hydrogen, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C1-C6)-haloalkyl or aryl, R 7 is hydrogen, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C4)-alkenyl or (C3-C4)-alkynyl, R 8 is hydrogen, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C3-C4)-alkenyl, (C1-C6)-alkyl-COO(C1-C2)-alkyl- or (C3-C4)-alkynyl, R 2 is (C1-C4)-alkylthio, R 3 is halogen, cyano, isocyano, nitro, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C1-C6)-haloalkyl, (C3-C6)-halocycloalkyl, (C1-C6)-alkylcarbonyl-, (C1-C6)-haloalkylcarbonyl-, (C1-C6)-alkyloxycarbonyl-, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C6)-alkyl-S(O) n and (C1-C6)-haloalkyl-S(O) n , CHO and NH2, R12 is halogen, cyano, nitro, (C1-C6)-alkyl or (C1-C6)-haloalkyl; R 13 is halogen, cyano, nitro, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C1-C6)-alkylcarbonyl, (C1-C6)-haloalkylcarbonyl, (C1-C6)-alkoxycarbonyl, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, (C1-C6)-alkylS(O) n , (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl or (C2-C3)-haloalkynyl, h is 0, 1 or 2; i is 0, 1, 2 or 3; k is 0, 1, 2, 3 or 4; m is 0, 1, 2 or 3; n is 0, 1 or 2; o is 0, 1 or 2; p is 0 or 1; q is 0 or 1; r is 3, 4, 5 or 6; s is 0, 1, 2, 3, 4 or 5. and its derivatives and its agriculturally acceptable salts, N-oxides, hydrates and hydrates of the salts and hydrates of the N-oxides thereof. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0015] Below, respective preferred, particularly preferred and very particularly preferred definitions of the individual substituents are given.

[0016] This results in various embodiments of the compounds of general formula (I).

[0017] preferable The compound represented by the general formula (I) A is selected from A1-1, A1-2, A1-3, A1-4, A2-1, A3-1, A3-2, A3-3, A3-4 and A3-5; [ka] Q is selected from the group consisting of Q1, Q2, Q9 and Q16; [ka] R 1 But, OR 1a or NR 9 R 10 and R 1a is hydrogen, or (C1-C6)-alkyl or (C3-C6)-cycloalkyl, which are unsubstituted or each independently COOR 5 , substituted by "m" radicals selected from the group consisting of halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C3-C6)-cycloalkyl, (C1-C6)-alkoxy, cyano and nitro, or (C3-C4)-alkenyl or (C3-C4)-alkynyl, or MeS-(C2-C3)-alkyl-, MeSO-(C2-C3)-alkyl, MeSO2-(C2-C3)-alkyl, or aryl-(C1-C2)-alkyl-, where the aryl radical is unsubstituted or substituted by "m" radicals each independently selected from the group consisting of halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl; R 9 is hydrogen or (C1-C4)-alkyl, R 10 is hydrogen, phenyl, (C1-C4)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, S(O) n R 5 , SO2NR 6 R 7wherein the above alkyl, alkenyl and alkynyl radicals are unsubstituted or each independently selected from halogen, cyano, S(O) n R 5 , CO2R 8 ,CONR 6 R 8 and is substituted with "m" radicals selected from the group consisting of: R 9 and R 10 together with the nitrogen atom to which they are attached, (C1-C4)-alkyl, (C1-C4)-haloalkyl, COR 8 and CONR 6 R 8 forming a saturated or partially or fully unsaturated 5-, 6- or 7-membered ring, which may be mono- or disubstituted by radicals from the group consisting of R 5 is (C1-C4)-alkyl, (C3-C6)-cycloalkyl, (C1-C4)-haloalkyl or phenyl, R 6 is hydrogen, (C1-C4)-alkyl, (C3-C6)-cycloalkyl, (C1-C4)-haloalkyl or phenyl, R 7 is hydrogen, (C1-C4)-alkyl, (C3-C6)-cycloalkyl, (C3-C4)-alkenyl or (C3-C4)-alkynyl, R 8 is hydrogen, (C1-C4)-alkyl, (C3-C6)-cycloalkyl, (C3-C4)-alkenyl or (C3-C4)-alkynyl, R 2 is (C1-C3)-alkylthio, R 3 is halogen, cyano, isocyano, nitro, (C1-C4)-alkyl, (C3-C6)-cycloalkyl, (C1-C6)-haloalkyl, (C3-C6)-halocycloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl or (C2-C3)-haloalkynyl, R 13is halogen, cyano, nitro, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, (C1-C6)-alkylS(O) n , (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl or (C2-C3)-haloalkynyl, i is 0, 1 or 2; k is 0, 1, 2 or 3; m is 0, 1 or 2; n is 0, 1 or 2; s is 0, 1, 2, 3, 4 or 5. It is a compound of the formula:

[0018] Particularly preferred The compound represented by the general formula (I) A is selected from A1-1, A1-2, A1-3, A1-4, A2-1, A3-1, A3-2, A3-3, A3-4 and A3-5; [ka] Q is selected from the group consisting of Q1, Q2, Q9 and Q16; [ka] R 1 But, OR 1a or NR 9 R 10 and R 1a is hydrogen, or (C1-C3)-alkyl, which is unsubstituted or substituted with a substituent selected from the group consisting of -C(O)2Me, cyclopropyl, methoxy, cyano, trifluoromethyl, or (C3-C6)-cycloalkyl, or phenyl-(C1-C2)-alkyl-, which is unsubstituted or substituted by "m" radicals, each independently selected from the group consisting of fluorine, chlorine, bromine, methyl, trifluoromethyl; R 9 is hydrogen, R 10 is (C1-C4)-alkyl (which is unsubstituted or COR 8 is monosubstituted by R 8 is methyl or ethyl, R 2 is methylthio or ethylthio, R 3 is halogen, cyano, nitro, (C1-C2)-alkyl, (C3-C5)-cycloalkyl, (C1-C2)-haloalkyl, (C3-C5)-halocycloalkyl, (C2-C3)-alkenyl or (C2-C3)-alkynyl, R 13 is fluorine, chlorine, bromine, cyano, methyl, ethyl, methoxy, ethoxy, CF3 or OCF3; i is 0, 1 or 2; k is 0, 1 or 2; m is 0, 1 or 2; s is 0, 1 or 2. It is a compound of the formula:

[0019] Very particularly preferred The compound represented by the general formula (I) A is selected from the group consisting of A1-1, A1-2, A1-3, A1-4, A2-1, A3-1, A3-2, A3-3, A3-4 and A3-5; [ka] Q is selected from the group consisting of Q1, Q9 and Q16; [ka] R 1 But, OR 1a and R 1a is hydrogen, ethyl, methyl, MeOOC(Me)CHCH2- or MeOOCCH2CH2-, R 2is methylthio or ethylthio, R 3 is fluorine, chlorine, bromine, iodine, cyano, nitro, cyclopropyl, 2,2-difluorocyclopropyl, ethenyl or CF3; R 13 is fluorine, chlorine, bromine, methyl or CF3; i is 0, 1 or 2; k is 0, 1 or 2; s is 0, 1 or 2. It is a compound of the formula:

[0020] Particularly preferred The compound represented by the general formula (I) A is selected from the group consisting of A1-2, A1-3, A3-1, A3-2, A3-3, A3-4 and A3-5; [ka] Q is selected from the group consisting of Q1, Q9 and Q16; [ka] R 1 But, OR 1a and R 1a is hydrogen, ethyl, methyl, MeOOC(Me)CHCH2- or MeOOCCH2CH2-, R 2 is methylthio, R 3 is chlorine, bromine, iodine, cyclopropyl, 2,2-difluorocyclopropyl, ethenyl or CF3; R 13 is fluorine, chlorine, bromine or methyl; i is 0 or 1, k is 0 or 1; s is 0, 1 or 2. It is a compound of the formula:

[0021] The present invention further relates to a compound of formula (Is) [ka] In one embodiment, the present invention provides a compound of the formula: in which the above definitions are applicable, including all preferred, particularly preferred and very particularly preferred definitions.

[0022] The present invention further relates to a compound of formula (It) [ka] In one embodiment, the present invention provides a compound of the formula: in which the above definitions are applicable, including all preferred, particularly preferred and very particularly preferred definitions.

[0023] The present invention further relates to a compound of formula (Iu) [ka] In one embodiment, the present invention provides a compound of the formula: in which the above definitions are applicable, including all preferred, particularly preferred and very particularly preferred definitions.

[0024] The present invention further relates to a compound represented by formula (Iv) [ka] In one embodiment, the present invention provides a compound of the formula: in which the above definitions are applicable, including all preferred, particularly preferred and very particularly preferred definitions.

[0025] The present invention further relates to a compound represented by the formula (Iw) [ka] In one embodiment, the present invention provides a compound of the formula: in which the above definitions are applicable, including all preferred, particularly preferred and very particularly preferred definitions.

[0026] The present invention further relates to a compound represented by formula (Ix) [ka] In one embodiment, the present invention provides a compound of the formula: in which the above definitions are applicable, including all preferred, particularly preferred and very particularly preferred definitions.

[0027] The present invention further relates to a compound represented by the formula (Iy) [ka] In one embodiment, the present invention provides a compound of the formula: in which the above definitions are applicable, including all preferred, particularly preferred and very particularly preferred definitions.

[0028] The present invention further relates to a compound represented by the formula (Iz) [ka] In one embodiment, the present invention provides a compound of the formula: in which the above definitions are applicable, including all preferred, particularly preferred and very particularly preferred definitions.

[0029] In all formulas specified below, the substituents and symbols have the same meanings as described in formula (I) unless defined differently.

[0030] Combinations which violate the laws of nature and which the skilled artisan would exclude based on his or her knowledge are not included.

[0031] Alkyl represents a saturated linear or branched hydrocarbon radical having the specified number of carbon atoms, e.g., C1-C 12-alkyl, preferably C1-C6-alkyl, such as methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl.

[0032] Halogen-substituted alkyl represents a linear or branched alkyl group in which some or all of the hydrogen atoms in these groups can be replaced by halogen atoms, for example C1-C6-haloalkyl, preferably C1-C2-haloalkyl, such as chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl and 1,1,1-trifluoroprop-2-yl.

[0033] Alkenylrepresents an unsaturated linear or branched hydrocarbon radical, each having the specified number of carbon atoms and one double bond in any position, for example C2-C8-alkenyl, preferably C2-C6-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3- Pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3- Hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-1-butenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1-butenyl, 3,3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl and 1-ethyl-2-methyl-2-propenyl.

[0034] Alkynyl represents a linear or branched hydrocarbon radical having the specified number of carbon atoms and one triple bond at any position, e.g., C2-C 12 -Alkynyl, preferably C2-C6-alkynyl, such as ethynyl, 1-propynyl, 2-propynyl (or propargyl), 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 3-methyl-1-butynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 3-methyl-1-pentynyl, butyl-1-methyl-2-propynyl, 4-methyl-1-pentynyl, 1-methyl-2-pentynyl, 4-methyl-2-pentynyl, 1-methyl-3-pentynyl, 2-methyl-3-pentynyl, 1-methyl-4-pentynyl, 2-methyl-4-pentynyl, 3-methyl-4-pentynyl, 1,1-dimethyl-2-butynyl, 1,1-dimethyl-3-butynyl, 1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl and 1-ethyl-1-methyl-2-propynyl.

[0035] Cycloalkylrepresents a carbocyclic saturated ring system preferably having 3 to 8 ring carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl. In the case of optionally substituted cycloalkyl, ring systems having substituents are included, including substituents having a double bond on the cycloalkyl radical, such as alkylidene groups, for example methylidene.

[0036] In the case of optionally substituted cycloalkyl, polycyclic aliphatic systems are also included, such as, for example, bicyclo[1.1.0]butan-1-yl, bicyclo[1.1.0]butan-2-yl, bicyclo[2.1.0]pentan-1-yl, bicyclo[2.1.0]pentan-2-yl, bicyclo[2.1.0]pentan-5-yl, bicyclo[2.2.1]hept-2-yl (norbornyl), adamantan-1-yl and adamantan-2-yl.

[0037] In the case of substituted cycloalkyl, spirocyclic aliphatic systems are also included, for example spiro[2.2]pent-1-yl, spiro[2.3]hex-1-yl and spiro[2.3]hex-4-yl, 3-spiro[2.3]hex-5-yl.

[0038] Cycloalkenyl represents a carbocyclic, non-aromatic, partially unsaturated ring system, preferably having 4 to 8 carbon atoms, such as 1-cyclobutenyl, 2-cyclobutenyl, 1-cyclopentenyl, 2-cyclopentenyl, 3-cyclopentenyl, or 1-cyclohexenyl, 2-cyclohexenyl, 3-cyclohexenyl, 1,3-cyclohexadienyl or 1,4-cyclohexadienyl, including substituents having a double bond on the cycloalkenyl radical, such as alkylidene groups, for example methylidene. In the case of optionally substituted cycloalkenyl, the explanations for substituted cycloalkyl apply analogously.

[0039] Alkoxyrepresents a saturated linear or branched alkoxy radical having the number of carbon atoms specified in each case, for example C1-C6-alkoxy, such as methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1,1-dimethylpropoxy, 1,2-dimethylbutoxy, 2,3-dimethylbutoxy, 2,4-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 1,4-dimethylbutoxy, 1,5-dimethylbutoxy, 1,6-dimethylbutoxy, 1,7-dimethylbutoxy, 1,8-dimethylbutoxy, 1,9-dimethylbutoxy, 2,10-dimethylbutoxy, 2,2-dimethylpropoxy, 1,6-dimethylbutoxy, 1,7-dimethylbutoxy, 2,10-dimethylbutoxy, 1,8-dimethylbutoxy, 1,9-dimethylbutoxy, 2,10-dimethylbutoxy, 1,9-dimethylbutoxy, 2,2-dimethylpropoxy, 1,6-dimethylbutoxy, 1,7-dimethylbutoxy, 1,8-dimethylbutoxy, 1,9-dimethylbutoxy, 2,10 ...2,10-dimethylbutoxy, 2,10-dimethylbutoxy, 2,10-dimethyl ethylpropoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy and 1-ethyl-2-methylpropoxy. Halogen-substituted alkoxy represents saturated, straight-chain or branched alkoxy radicals having the number of carbon atoms specified in each case, in which some or all of the hydrogen atoms in these groups can be replaced by halogen atoms as specified above, for example C1-C2-haloalkoxy, such as chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-1,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy and 1,1,1-trifluoroprop-2-oxy.

[0040] Arylrepresents phenyl, which may be substituted by 0 to 5 radicals from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxy, (C1-C3)-alkyl, (C1-C3)-alkoxy, (C3-C4)-cycloalkyl, (C2-C3)-alkenyl or (C2-C3)-alkynyl.

[0041] Heterocyclic radical (Heterocyclyl)contains at least one heterocyclic ring (= a carbocyclic ring in which at least one carbon atom is replaced by a heteroatom, preferably from the group N, O, S, P), which ring may be saturated, unsaturated, partially saturated or heteroaromatic, and may be unsubstituted or substituted, in which case the binding site is localized on a ring atom. If the heterocyclic radical or heterocyclic ring is optionally substituted, it may be fused to other carbocyclic or heterocyclic rings. In the case of optionally substituted heterocyclyl, polycyclic ring systems such as 8-azabicyclo[3.2.1]octanyl, 8-azabicyclo[2.2.2]octanyl or 1-azabicyclo[2.2.1]heptyl are also included. In the case of optionally substituted heterocyclyl, spiro ring systems such as 1-oxa-5-azaspiro[2.3]hexyl are also included. Unless otherwise defined, the heterocyclic ring preferably contains 3 to 9 ring atoms, in particular 3 to 6 ring atoms, and in the heterocyclic ring, one or more, preferably 1 to 4, in particular 1, 2 or 3 heteroatoms, preferably from the group N, O and S, but two oxygen atoms must not be directly adjacent to each other, for example those with one heteroatom from the group consisting of N, O and S are: 1- or 2- or 3-pyrrolidinyl, 3,4-dihydro-2H-pyrrol-2- or 3-yl, 2,3-dihydro-1H-pyrrol-1- or 2- or 3- or 4- or -5-yl; 2,5-dihydro-1H-pyrrol-1- or 2- or 3-yl, 1- or is 2- or 3- or 4-piperidinyl; 2,3,4,5-tetrahydropyridin-2- or 3- or 4- or 5-yl or 6-yl; 1,2,3,6-tetrahydropyridin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,2,3,4-tetrahydropyridin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,4-dihydropyridin-1- or 2- or 3- or 4-yl; 2,3-dihydropyridin-2- or 3- or 4- or 5- or 6-yl; 2,5-dihydropyridin-2- or 3- or 4- or 5- or 6-yl, 1- or 2- or 3- or 4-azepanyl;2,3,4,5-Tetrahydro-1H-azepin-1- or 2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydro-1H-azepin-1- or 2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydro-1H-azepin-1- or 2- or 3- or 4-yl; 3,4,5,6-Tetrahydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-Dihydro-1H-azepin-1- or 2- or 3- or 4 -yl;2,5-dihydro-1H-azepin-1- or 2- or 3- or 4- or 5- or 6- or 7-yl;2,7-dihydro-1H-azepin-1- or 2- or 3- or 4-yl;2,3-dihydro-1H-azepin-1- or 2- or 3- or 4- or 5- or 6- or 7-yl;3,4-dihydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl;3,6-dihydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl;5,6-dihydro 4,5-dihydro-3H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 1H-azepin-1- or 2- or 3- or 4- or 5- or 6- or 7-yl; 2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 3H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl, 2- or 3-oxolanyl (= 2- or 3-tetrahydrofuranyl); 2,3-dihydrofuran-2- or 3- or 4- or 5-yl; 2,5-dihydrofuran-2- or 3-yl, 2- or 3- or 4-oxanyl (= 2- or 3- or 4-tetrahydropyranyl); 3,4-dihydro-2H-pyran-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-pyran-2- or 3- or 4- or 5- or 6-yl; 2H-pyran-2- or 3- or 4- or 5- or 6-yl;4H-Pyran-2- or 3- or 4-yl; 2- or 3- or 4-oxepanyl; 2,3,4,5-tetrahydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-tetrahydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-tetrahydrooxepin-2- or 3- or 4-yl; 2,3-dihydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-dihydrooxepin-2- or 3- or 4-yl; 2,5-dihydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl ;oxepin-2- or 3- or 4- or 5- or 6- or 7-yl;2- or 3-tetrahydrothiophenyl;2,3-dihydrothiophen-2- or 3- or 4- or 5-yl;2,5-dihydrothiophen-2- or 3-yl;tetrahydro-2H-thiopyran-2- or 3- or 4-yl;3,4-dihydro-2H-thiopyran-2- or 3- or 4- or 5- or 6-yl;3,6-dihydro-2H-thiopyran-2- or 3- or 4- or 5- or 6-yl;2H-thiopyran-2- or 3- or 4- or 5- or 6-yl;4H-thiopyran-2- or 3- or 4-yl. Preferred 3- and 4-membered heterocyclyls are, for example, 1- or 2-aziridinyl, oxiranyl, thiiranyl, 1-, 2- or 3-azetidinyl, 2- or 3-oxetanyl, 2- or 3-thietanyl, 1,3-dioxetan-2-yl. Further examples of "heterocyclyl" are partially or fully hydrogenated heterocyclic radicals having two heteroatoms from the group N, O and S, such as 1- or 2- or 3- or 4-pyrazolidinyl; 4,5-dihydro-3H-pyrazol-3- or 4- or 5-yl, 4,5-dihydro-1H-pyrazol-1- or 3- or 4- or 5-yl; 2,3-dihydro-1H-pyrazol-1- or 2- or 3- or 4- or 5-yl; 1- or 2- or 3- or 4-imidazolidinyl; 2,3-dihydro-1H-imidazol-1- or 2- or 3- or 4-yl;2,5-Dihydro-1H-imidazol-1- or 2- or 4- or 5-yl;4,5-Dihydro-1H-imidazol-1- or 2- or 4- or 5-yl;Hexahydropyridazin-1- or 2- or 3- or 4-yl;1,2,3,4-Tetrahydropyridazin-1- or 2- or 3- or 4- or 5- or 6-yl;1,2,3,6-Tetrahydropyridazin-1- or 2- or 3- or 4- or 5- or 6-yl;1,4,5,6-Tetrahydropyridazin-1- or 3- or 4- or 5- or or 6-yl;3,4,5,6-tetrahydropyridazin-3- or 4- or 5-yl;4,5-dihydropyridazin-3- or 4-yl;3,4-dihydropyridazin-3- or 4- or 5- or 6-yl;3,6-dihydropyridazin-3- or 4-yl;1,6-dihydropyridazin-1- or 3- or 4- or 5- or 6-yl;hexahydropyrimidin-1- or 2- or 3- or 4-yl;1,4,5,6-tetrahydropyrimidin-1- or 2- or 4- or 5- or 6-yl;1,2,5,6- Tetrahydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1,2,3,4-tetrahydropyrimidin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,6-dihydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1,2-dihydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 2,5-dihydropyrimidin-2- or 4- or -5-yl; 4,5-dihydropyrimidin-4- or 5- or 6-yl; 1,4-dihydropyrimidin-1- or 2- or 4- or 5- or 6-yl;1- or 2- or 3-piperazinyl;1,2,3,6-tetrahydropyrazin-1- or 2- or 3- or 5- or 6-yl;1,2,3,4-tetrahydropyrazin-1- or 2- or 3- or 4- or 5- or 6-yl;1,2-dihydropyrazin-1- or 2- or 3- or 5- or 6-yl;1,4-dihydropyrazin-1- or 2- or 3-yl;2,3-dihydropyrazin-2- or 3- or 5- or 6-yl;2,5-dihydropyrazin-2- or 3-yl;1,3-Dioxolane-2- or 4- or 5-yl;1,3-Dioxol-2- or 4- or 5-yl;1,3-Dioxan-2- or 4- or 5-yl;4H-1,3-Dioxin-2- or 4- or 5- or 6-yl;1,4-Dioxan-2- or 3- or 5- or 6-yl;2,3-Dihydro-1,4-dioxin-2- or 3- or 5- or 6-yl;1,4-Dioxin-2- or -3-yl;1,2-Dithiolan-3- or 4-yl;3H-1,2-Dithiol-3- or 4- or 5-yl;1 ,3-Dithiolane-2- or 4-yl;1,3-Dithiol-2- or 4-yl;1,2-Dithiane-3- or 4-yl;3,4-Dihydro-1,2-dithiin-3- or 4- or 5- or 6-yl;3,6-Dihydro-1,2-dithiin-3- or 4-yl;1,2-Dithiin-3- or 4-yl;1,3-Dithiane-2- or 4- or 5-yl;4H-1,3-Dithiin-2- or 4- or 5- or 6-yl;Isoxazolidine-2- or 3- or 4- or 5-yl;2,3-Dihydroisoxazole -2- or 3- or 4- or 5-yl;2,5-dihydroisoxazol-2- or 3- or 4- or 5-yl;4,5-dihydroisoxazol-3- or 4- or 5-yl;1,3-oxazolidine-2- or 3- or 4- or 5-yl;2,3-dihydro-1,3-oxazol-2- or 3- or 4- or 5-yl;2,5-dihydro-1,3-oxazol-2- or 4- or 5-yl;4,5-dihydro-1,3-oxazol-2- or 4- or 5-yl;1,2-oxazinane-2 - or 3- or 4- or 5- or 6-yl;3,4-dihydro-2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl;3,6-dihydro-2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl;5,6-dihydro-2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl;5,6-dihydro-4H-1,2-oxazin-3- or 4- or 5- or 6-yl;2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl;6H-1,2-oxazin-3- or 4- or 5- or 6-yl; 4H-1,2-oxazin-3- or 4- or 5- or 6-yl; 1,3-oxazinan-2- or 3- or 4- or 5- or 6-yl; 3,4-dihydro-2H-1,3-oxazin-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-1,3-oxazin-2- or 3- or 4- or 5- or 6-yl; 5,6-dihydro; 5,6-dihydro-4H-1,3-oxazin-2- or 4- or 5- or 6-yl; 2H-1,3-oxazin-2- or 4- or 5- or 6-yl; 6H-1,3-oxazin-2- or 4- or 5- or 6-yl; 4H-1,3-oxazin-2- or 4- or 5- or 6-yl; morpholin-2- or 3- or 4-yl; 3,4-dihydro-2H-1,4-oxazin-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-1,4-oxazin-2- or 3- or 5- or 6-yl;2H-1,4-oxazin-2- or 3- or 5- or 6-yl;4H-1,4-oxazin-2- or 3-yl;1,2-oxazepan-2- or 3- or 4- or 5- or 6- or 7-yl;2,3,4,5-tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl;2,3,4,7-tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl;2,3,6,7-tetrahydro-1,2-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl;2,5,6,7-tetrahydro-1,2-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl;4,5,6,7-tetrahydro-1,2-oxazepine-3- or 4- or 5- or 6- or 7-yl;2,3-dihydro-1,2-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl;2,5-dihydro-1,2-oxazepine-2- or 3 - or 4- or 5- or 6- or 7-yl;2,7-dihydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl;4,5-dihydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl;4,7-dihydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl;6,7-dihydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl;1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl;1,3-Oxazepan-2- or 3- or 4- or 5- or 6- or 7-yl;2,3,4,5-Tetrahydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl;2,3,4,7-Tetrahydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl;2,3,6,7-Tetrahydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl;2,5,6,7-Tetrahydro-1,3-oxazepin-2- or 4- or or 5- or 6- or 7-yl;4,5,6,7-tetrahydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl;2,3-dihydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl;2,5-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl;2,7-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl;4,5-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl;4,7-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl;6,7-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl;1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl;1,4-oxazepan-2- or 3- or 5- or 6- or 7-yl;2,3,4,5-tetrahydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl;2,3,4,7-tetrahydro- 1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl;2,3,6,7-tetrahydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl;2,5,6,7-tetrahydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl;4,5,6,7-tetrahydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl;2,3-dihydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl;2,5-dihydro-1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl; 2,7-dihydro-1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl; 4,5-dihydro-1,4-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 4,7-dihydro-1,4-oxazepine-2- or 3- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1,4-oxazepine-2- or 3- or 5- or 6- or 7-yl;1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl;isothiazolidine-2- or 3- or 4- or 5-yl;2,3-dihydroisothiazol-2- or 3- or 4- or 5-yl;2,5-dihydroisothiazol-2- or 3- or 4- or 5-yl;4,5-dihydroisothiazol-3- or 4- or 5-yl;1,3-thiazolidine-2- or 3- or 4- or 5-yl;2,3-dihydro-1,3-thiazol-2- or 3- or 4- or 5-yl;2,5-dihydro-1,3-thiazol-2- or 4- or 5-yl;4,5-dihydro-1,3-thiazol-2- or 4- or 5-yl;1,3-thiazinane-2- or 3- or 4- or 5- or 6-yl;3,4-dihydro-2H-1,3-thiazin-2- or 3- or 4- or 5- or 6-yl;3,6-dihydro-2H-1, 3-thiazin-2- or 3- or 4- or 5- or 6-yl; 5,6-dihydro-2H-1,3-thiazin-2- or 4- or 5- or 6-yl; 5,6-dihydro-4H-1,3-thiazin-2- or 4- or 5- or 6-yl; 2H-1,3-thiazin-2- or 4- or 5- or 6-yl; 6H-1,3-thiazin-2- or 4- or 5- or 6-yl; 4H-1,3-thiazin-2- or 4- or 5- or 6-yl. Further examples of "heterocyclyl" are partially or fully hydrogenated heterocyclic radicals having three heteroatoms from the group N, O and S, such as 1,4,2-dioxazolidine-2- or 3- or 5-yl; 1,4,2-dioxazol-3- or 5-yl;1,4,2-dioxazinane-2- or 3- or 5- or 6-yl; 5,6-dihydro-1,4,2-dioxazin-3- or 5- or 6-yl; 1,4,2-dioxazin-3- or 5- or 6-yl; 1,4,2-dioxazepane-2- or 3- or 5- or 6- or 7-yl; 6,7-dihydro-5H-1,4,2-dioxazepine-3- or 5- or 6- or 7-yl yl; 2,3-dihydro-7H-1,4,2-dioxazepin-2- or 3- or 5- or 6- or 7-yl; 2,3-dihydro-5H-1,4,2-dioxazepin-2- or 3- or 5- or 6- or 7-yl; 5H-1,4,2-dioxazepin-3- or 5- or 6- or 7-yl; 7H-1,4,2-dioxazepin-3- or 5- or 6- or 7-yl. Examples of the structure of heterocyclyl which may be further substituted are also shown below. [ka]

[0042] TIFF2024542693000022.tif240166

[0043] TIFF2024542693000023.tif116166

[0044] The heterocycles listed above are preferably selected from the group consisting of hydrogen, halogen, alkyl, haloalkyl, hydroxyl, alkoxy, cycloalkoxy, aryloxy, alkoxyalkyl, alkoxyalkoxy, cycloalkyl, halocycloalkyl, aryl, arylalkyl, heteroaryl, heterocyclyl, alkenyl, alkylcarbonyl, cycloalkylcarbonyl, arylcarbonyl, heteroarylcarbonyl, alkoxycarbonyl, hydroxycarbonyl, cycloalkoxycarbonyl, cycloalkylalkoxycarbonyl, alkoxycarbonylalkyl, arylalkoxycarbonyl, arylalkoxycarbonylalkyl, alkynyl, alkynylalkyl, alkylalkynyl, trisalkylsilylalkynyl, nitro, amino, cyano, haloalkoxy, haloalkoxy. and substituted by arylthio, alkylthio, hydrothio, hydroxyalkyl, oxo, heteroarylalkoxy, arylalkoxy, heterocyclylalkoxy, heterocyclylalkylthio, heterocyclyloxy, heterocyclylthio, heteroaryloxy, bisalkylamino, alkylamino, cycloalkylamino, hydroxycarbonylalkylamino, alkoxycarbonylalkylamino, arylalkoxycarbonylalkylamino, alkoxycarbonylalkyl(alkyl)amino, aminocarbonyl, alkylaminocarbonyl, bisalkylaminocarbonyl, cycloalkylaminocarbonyl, hydroxycarbonylalkylaminocarbonyl, alkoxycarbonylalkylaminocarbonyl, arylalkoxycarbonylalkylaminocarbonyl.

[0045] If a base structure is substituted "by one or more radicals" from a list (=group) of radicals or a generally defined group of radicals, this includes simultaneous substitution by multiple identical and / or structurally different radicals, respectively.

[0046] In the case of a partially or fully saturated nitrogen heterocycle, it can be attached to the remainder of the molecule through a carbon or through a nitrogen.

[0047] Suitable substituents for substituted heterocyclic radicals are the above-mentioned substituents, and also oxo and thioxo. The oxo group as a substituent on a ring carbon atom is, for example, a carbonyl group in a heterocycle. As a result, lactones and lactams are also preferably included. The oxo group may also be present on a ring heteroatom, which may be present in various oxidation states, for example in the case of N and S, forming, for example, divalent -N(O)-, -S(O)- (also abbreviated SO) and S(O)2 (also abbreviated SO2) groups in the heterocycle. In the case of -N(O)- and -S(O)- groups, both enantiomers in each case are included.

[0048] According to the present invention, "Heteroaryl"The expression denotes heteroaromatic compounds, i.e. fully unsaturated aromatic heterocyclic compounds, preferably with 5-7 membered rings and with 1-4, preferably 1 or 2 identical or different heteroatoms, preferably O, S or N. Heteroaryls of the invention are, for example, 1H-pyrrol-1-yl; 1H-pyrrol-2-yl; 1H-pyrrol-3-yl; furan-2-yl; furan-3-yl; thien-2-yl; thien-3-yl, 1H-imidazol-1-yl; 1H-imidazol-2-yl; 1H-imidazol-4-yl; 1H-imidazol-5-yl; 1H-pyrazol-1-yl; 1H-pyrazol-3-yl; 1H-pyrazol-4-yl; 1H-pyrazol-5-yl, 1H-1,2,3-triazolyl, 1H-pyrrol-2-yl; 1H-pyrrol-3-yl; 1H-pyrazol-4-yl; 1H-pyrazol-5-yl, 1H-1,2,3-triazolyl, 1H-pyrrol-1-yl; 1H-pyrazol ... 1H-1,2,3-triazol-4-yl, 1H-1,2,3-triazol-5-yl, 2H-1,2,3-triazol-2-yl, 2H-1,2,3-triazol-4-yl, 1H-1,2,4-triazol-1-yl, 1H-1,2,4-triazol-3-yl, 4H-1,2,4-triazol-4-yl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl, 1,3,4-oxadiazol-2-yl, 1,2,3-oxadiazol-1-yl, 1H- ...1-yl, 1H-1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl, 1,3,4-oxadiazol-2-yl, 1,2,3-oxadiazol-1-yl, 1H-1,2,4-oxadiazol-1-yl, 1H-1,2,4-oxadiazol-1-yl, 1H-1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl, 1,3,4-oxadiazol-2-yl, 1,2,3-oxadiazol-1-yl, 1H-1,2 4-diazolyl, 1,2,3-oxadiazol-5-yl, 1,2,5-oxadiazol-3-yl, azepinyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 2-pyrazinyl, 3-pyrazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 3-pyridinyl, 4-pyridinyl, 1,3,5-triazin-2-yl, 1,2,4-triazin-3-yl, 1,2,4-triazin-5-yl, 1,2,4-triazinyl 1,2,3-triazin-4-yl, 1,2,3-triazin-5-yl, 1,2,4-, 1,3,2-, 1,3,6- and 1,2,6-oxazinyl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, 1,3-oxazol-2-yl, 1,3-oxazol-4-yl, 1,3-oxazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,3-thiazol-2-yl, 1,3-thiazol-4-yl, 1,3-thiazol-5-yl, oxepinyl, thiepinyl, 1,2,4-triazolonyl and 1,2,4-diazepinyl, 2H-1,2,3,4-tetrazol-5-yl, 1H-1,2,3,4-tetrazol-5-yl, 1,2,3,4-oxatriazol-5-yl, 1,2,3,4-thiatriazol-5-yl, 1,2,3,5-oxatriazol-4-yl, 1,2,3,5-thiatriazol-4-yl. Heteroaryl groups according to the invention may also be substituted by one or more identical or different radicals. When two adjacent carbon atoms are part of a further aromatic ring, the system is a fused heteroaromatic system, such as a benzo-fused or fused polycyclic heteroaromatic system. Preferred examples are quinolines (e.g., quinolin-2-yl, quinolin-3-yl, quinolin-4-yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl, quinolin-8-yl); isoquinolines (e.g., isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4-yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl, isoquinolin-8-yl); quinoxaline; quinazoline; cinnoline; 1,5-naphthyridine; 1,6-naphthyridine; 1,7-naphthyridine; 1,8-naphthyridine; 2,6-naphthyridine; 2,7-naphthyridine; phthalazine; pyridopyrazines; pyridopyrimidines; pyridopyridazines; pteridines; pyrimidopyrimidines. Examples of heteroaryl are also 1H-indol-1-yl, 1H-indol-2-yl, 1H-indol-3-yl, 1H-indol-4-yl, 1H-indol-5-yl, 1H-indol-6-yl, 1H-indol-7-yl, 1-benzofuran-2-yl, 1-benzofuran-3-yl, 1-benzofuran-4-yl, 1-benzofuran-5-yl, 1-benzofuran-6-yl, 1-benzofuran-7-yl, 1-benzothiophen-2-yl, 1-benzothiophen ... 1H-indazol-4-yl, 1-benzothiophen-5-yl, 1-benzothiophen-6-yl, 1-benzothiophen-7-yl, 1H-indazol-1-yl, 1H-indazol-3-yl, 1H-indazol-4-yl, 1H-indazol-5-yl, 1H-indazol-6-yl, 1H-indazol-7-yl, 2H-indazol-2-yl, 2H-indazol-3-yl, 2H-indazol-4-yl, 2H-indazol-5-yl, 2H-indazol-6-yl, 2H-indazol 2H-Isoindol-7-yl, 2H-Isoindol-2-yl, 2H-Isoindol-1-yl, 2H-Isoindol-3-yl, 2H-Isoindol-4-yl, 2H-Isoindol-5-yl, 2H-Isoindol-6-yl; 2H-Isoindol-7-yl, 1H-Benzoimidazol-1-yl, 1H-Benzoimidazol-2-yl, 1H-Benzoimidazol-4-yl, 1H-Benzoimidazol-5-yl, 1H-Benzoimidazol-6-yl, 1H-Benzoimidazol-7-yl , 1,3-benzoxazol-2-yl, 1,3-benzoxazol-4-yl, 1,3-benzoxazol-5-yl, 1,3-benzoxazol-6-yl, 1,3-benzoxazol-7-yl, 1,3-benzothiazol-2-yl, 1,3-benzothiazol-4-yl, 1,3-benzothiazol-5-yl, 1,3-benzothiazol-6-yl, 1,3-benzothiazol-7-yl, 1,2-benzoisoxazol-3-yl, 1,2-benzoisoxazol-4-yl, 1,5- or 6-membered benzo-fused rings from the group: 2-benzisoxazol-5-yl, 1,2-benzisoxazol-6-yl, 1,2-benzisoxazol-7-yl, 1,2-benzisothiazol-3-yl, 1,2-benzisothiazol-4-yl, 1,2-benzisothiazol-5-yl, 1,2-benzisothiazol-6-yl, 1,2-benzisothiazol-7-yl.

[0049] The term "halogen" means fluorine, chlorine, bromine or iodine. When the term is used in a radical, "halogen" means a fluorine, chlorine, bromine or iodine atom.

[0050] According to the nature of the substituents defined above, the compounds of formula (I) have acidic properties and can form salts, and where appropriate also adducts or inner salts with inorganic or organic bases or metal ions. When the compounds of formula (I) have hydroxyl groups, carboxyl groups or other groups that induce acidic properties, these compounds can be reacted with bases to obtain salts. Suitable bases are, for example, hydroxides, carbonates, hydrogen carbonates of alkali metals and alkaline earth metals, in particular sodium, potassium, magnesium and calcium, but also ammonia, primary, secondary and tertiary amines with (C1-C4)-alkyl groups, mono-, di- and trialkanolamines of (C1-C4)-alkanols, choline and chlorocholine, and organic amines such as trialkylamines, morpholine, piperidine or pyridine. These salts are those in which the acidic hydrogen is replaced by a cation suitable in agriculture, such as metal salts, in particular alkali metal salts or alkaline earth metal salts, in particular sodium salts or potassium salts, or ammonium salts, salts with organic amines or quaternary ammonium salts, such as salts of the formula [NRR'R''R'''] +where R-R''' each independently represent an organic radical, particularly alkyl, aryl, arylalkyl, or alkylaryl. Also useful are alkylsulfonium salts and alkylsulfoxonium salts, such as (C1-C4)-trialkylsulfonium and (C1-C4)-trialkylsulfoxonium salts.

[0051] The compounds of formula (I) can form salts by addition of suitable inorganic or organic acids, such as mineral acids, for example HCl, HBr, H2SO4, H3PO4 or HNO3, or organic acids, such as carboxylic acids, for example formic acid, acetic acid, propionic acid, oxalic acid, lactic acid or salicylic acid, or sulfonic acids, for example p-toluenesulfonic acid, onto basic groups, for example amino, alkylamino, dialkylamino, piperidino, morpholino or pyridino, which contain the conjugate base of the acid as the anion.

[0052] Suitable substituents that exist in deprotonated form, such as sulfonic acids or carboxylic acids, can form inner salts with groups on the moiety that can be protonated, such as an amino group.

[0053] If a group is polysubstituted by a radical, this means that the group is substituted by one or more radicals which may be identical or different from the ones mentioned.

[0054] In all formulas specified below, the substituents and symbols, unless defined differently, have the same meaning as described in formula (I). Arrows in chemical formulas indicate the points of attachment to the remainder of the molecule.

[0055] Below are set out the respective preferred, particularly preferred and very particularly preferred definitions of the individual substituents. The other substituents of the general formula (I) which are not specified below have the above definitions.

[0056] The compounds of the present invention of general formula (I) have a chiral carbon atom at the second carbon of the alkyl acid structure, which is indicated by a marker (*) in the structure shown below. [ka]

[0057] According to the Cahn-Ingold-Prelog (CIP) rules, this carbon atom can have either the (R) or the (S) configuration.

[0058] The present invention encompasses compounds of general formula (I) in both the (S) and (R) configuration, which means that the present invention is based on the assumption that the carbon atom in question is (1) (R) Placement, or (2) (S) Placement The present invention is meant to encompass compounds having the general formula (I):

[0059] Furthermore, the scope of the present invention also includes (3) Any mixture of a compound of general formula (I) having the (R) configuration (a compound of general formula (I-(R))) and a compound of general formula (I) having the (S) configuration (a compound of general formula (IS)) is included, and the present invention also includes a racemic mixture of a compound of general formula (I) having the (R) configuration and the (S) configuration.

[0060] Furthermore, depending on the respective radicals selected, further steric elements may be present in the inventive compounds of general formula (I).

[0061] Examples of compounds of general formula (I) are given below in tabular form.

[0062] Table 1: [ka] [Table 1]

[0063] TIFF2024542693000027.tif236170

[0064] TIFF2024542693000028.tif240170

[0065] TIFF2024542693000029.tif242170

[0066] TIFF2024542693000030.tif126170

[0067] A further aspect of the present invention relates to the preparation of the compounds of the present invention of general formula (I).The compounds of the present invention can be prepared in a variety of ways.

[0068] The compounds of general formula (Ib) according to the present invention are synthesized via amide coupling between the inventive acid of general formula (Ia) and the amine of general formula (II) in the presence of an amide coupling reagent, such as T3P, dicyclohexylcarbodiimide, N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide, N,N'-carbonyldiimidazole, 2-chloro-1,3-dimethylimidazolium chloride or 2-chloro-1-methylpyridinium iodide, as shown in scheme 1 (see Chemistry of Peptide Synthesis, edited by N.Leo Benoiton, Taylor & Francis, 2006, ISBN-10:1-57444-454-9). Polymer-bound reagents, such as polymer-bound dicyclohexylcarbodiimide, are also suitable for this coupling reaction. The reaction is preferably carried out in a suitable solvent such as dichloromethane, acetonitrile, N,N-dimethylformamide or ethyl acetate in the presence of a base such as triethylamine, N,N-diisopropylethylamine or 1,8-diazabicyclo[5.4.0]undec-7-ene at a temperature preferably in the range of 0° C. to 80° C. For peptide coupling conditions of T3P, see Organic Process Research & Development 2009, 13, 900-906. [ka]

[0069] The acids of general formula (Ia) can be prepared by hydrolysis of the esters of the invention of general formula (Ic) or similarly by standard methods well known to those skilled in the art (Scheme 2). The hydrolysis of the esters can be carried out in the presence of a base or a Lewis acid. The base can be a hydroxide salt of an alkali metal (e.g., lithium, sodium or potassium), and the hydrolysis reaction is preferably carried out within a temperature range of room temperature to 120°C. [ka]

[0070] Compounds of general formula (Ic) are synthesized, for example, by alkylating 3-hydroxypyrazoles of general formula (III) with halides of general formula (IV) in the presence of a base, or in a similar manner known to those skilled in the art (see scheme 3). As bases, carbonates of alkali metals can be used. As bases, carbonates of alkali metals selected from the group consisting of lithium, sodium, potassium and cesium are preferred. The reaction is preferably carried out in a suitable solvent, such as dichloromethane, acetonitrile, N,N-dimethylformamide or ethyl acetate, at a temperature range from room temperature to 150°C. See, for example, J.Med.Chem.2011, 54(16), 5820-5835 and WO2010 / 010154. The "X" radical in compounds of general formula (IV) is preferably chlorine, bromine or iodine. [ka]

[0071] In Scheme 4, a compound represented by the general formula (III) 3 =Cl, Br, I] by reaction of 3-hydroxypyrazoles of the general formula (III-a) with electrophilic halogenating agents of the general formula (VI), such as N-chlorosuccinimide (VI, X=Cl), N-bromosuccinimide (VI, X=Br) or N-iodosuccinimide (VI, X=I). Similarly, the synthesis of other electrophilic reagents, such as nitric acid, nitronium tetrafluoroborate or ammonium nitrate / trifluoroacetic acid (R 3 Electrophilic nitration reagents such as DAST, Selectfluor or N-fluorobenzenesulfonimide (R = nitro) 3 ═F) may also be used. The reaction is preferably carried out in a suitable solvent such as N,N-dimethylformamide, 1,2-dichloroethane or acetonitrile at a temperature range of 0° C. to 120° C. [ka]

[0072] The general formula (III) described in Scheme 4, 3 = halogen, preferably R 3 =Br, I] can be used in a similar manner to methods well known to those skilled in the art, for example in a Sonogashira or Suzuki coupling, to give a compound of formula R 3 -B(OR b )(OR C ) [In the formula, R b and R C The radicals are independently, for example, hydrogen, (C1-C4)-alkyl, or R b and R C and when the radicals are bonded to each other, they are collectively ethylene or propylene, to further prepare compounds of general formula (III), 3 can be prepared, for example, (C1-C6)-alkyl, (C2-C3)-alkenyl, (C2-C3)-alkynyl or (C3-C6)-cycloalkyl, in particular cyclopropyl.

[0073] 3-Hydroxypyrazoles (III-a) can be prepared in a two-step synthesis from substituted 3-azinylpropynoic acid derivatives (X) and phenylhydrazines (XII) (Scheme 5) in analogy to methods known in the literature, as described, for example, in Adv. Synth. Catal. 2014, 356, 3135-3147, or from substituted azinylacrylic acid derivatives and phenylhydrazines (Scheme 6; for example, according to J. Heterocyclic Chem., 49, 130 (2012)). [ka]

[0074] Compounds of general formula (XII) are synthesized here via amide coupling between acids of general formula (X) and aryl or hetaryl hydrazines of general formula (XI) in the presence of amide coupling reagents such as T3P, dicyclohexylcarbodiimide, N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide, N,N'-carbonyldiimidazole, 2-chloro-1,3-dimethylimidazolium chloride or 2-chloro-1-methylpyridinium iodide (see Chemistry of Peptide Synthesis, edited by N.Leo Benoiton, Taylor & Francis, 2006, ISBN-10:1-57444-454-9). Polymer-bound reagents such as polymer-bound dicyclohexylcarbodiimide are also suitable for this coupling reaction. The reaction is preferably carried out in a suitable solvent, such as dichloromethane, tetrahydrofuran, acetonitrile, N,N-dimethylformamide or ethyl acetate, at a temperature range of 0°C to 80°C, in the presence of a base, such as triethylamine, N,N-diisopropylethylamine or 1,8-diazabicyclo[5.4.0]undec-7-ene. For peptide coupling conditions of T3P, see, for example, Organic Process Research & Development 2009, 13, 900-906. This is followed by cyclization of the hydrazide (XII) in the presence of a base, such as a copper halide, such as copper(I) iodide, copper(I) bromide, or sodium methoxide, or an acid, such as methanesulfonic acid. The reaction is preferably carried out in a suitable solvent, such as 1,2-dichloroethane, acetonitrile, N,N-dimethylformamide, n-propanol or ethyl acetate, at a temperature range of 0°C to 120°C.

[0075] Alternatively, 3-hydroxypyrazoles of general formula (III-a) are synthesized from substituted azinylacrylic acid derivatives (XIV) and phenylhydrazines (XI) as shown in Scheme 6. [ka]

[0076] Compounds of general formula (XV) can now be prepared via amide coupling of substituted acids of general formula (XIV) with aryl or hetaryl hydrazines of general formula (XI) in the presence of amide coupling reagents such as T3P, dicyclohexylcarbodiimide, N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide, N,N'-carbonyldiimidazole, 2-chloro-1,3-dimethylimidazolium chloride or 2-chloro-1-methylpyridinium iodide. The reaction is preferably carried out in a temperature range of 0°C to 80°C in a suitable solvent such as dichloromethane, acetonitrile, N,N-dimethylformamide or ethyl acetate in the presence of a base such as triethylamine, N,N-diisopropylethylamine or 1,8-diazabicyclo[5.4.0]undec-7-ene (see scheme 6). 3-Hydroxypyrazoles of general formula (III-a) are synthesized in a second reaction step by reacting compounds of general formula (XV) in the presence of an iron halide, such as iron(III) chloride. The reaction is preferably carried out in a suitable solvent, such as 1,2-dichloroethane, acetonitrile, N,N-dimethylformamide or ethyl acetate, at a temperature range of preferably 0° C. to 120° C.

[0077] Alternatively, the compound Ic of the present invention (wherein R 3 =Cl, Br, I) can also be synthesized by reacting 4-unsubstituted pyrazoles of general formula (XIII) with halosuccinimides of general formula (VI) in a suitable solvent, such as N,N-dimethylformamide, as shown in Scheme 7. 4H-pyrazoles of general formula (XIII) can be obtained from 3-hydroxypyrazoles of general formula (III-a) as shown in Schemes 5 and 6 by alkylation, as described in Scheme 3.

[0078] The 4-cyanopyrazole of general formula (Id) can then be reacted with, for example, a compound of formula (Ic) 3 = halogen, preferably R 34-Halopyrazoles of the formula (I) (wherein 4-halopyrazole is Br, I) can be prepared by reacting a metal cyanide M-CN or M(CN)2(VIII) with an appropriate amount of a transition metal catalyst, especially a palladium catalyst, such as palladium(0) tetrakis(triphenylphosphine) or palladium diacetate or bis(triphenylphosphine)palladium(II) dichloride, or a nickel catalyst, such as nickel(II) acetylacetonate or bis(triphenylphosphine)nickel(II) chloride, in a suitable solvent, preferably in an organic solvent, such as 1,2-dimethoxyethane or N,N-dimethylformamide, preferably at elevated temperatures (Scheme 7). The "M" radical in the metal cyanide M-CN or M(CN)2(VII) represents, for example, magnesium, zinc, lithium or sodium. [ka]

[0079] The compound represented by the general formula (Ic) in Scheme 7, 3 = halogen, preferably R 3=Br, I) can be used in a similar manner to prepare further compounds of the invention of formula (I). Generally suitable cross-coupling methods are described in RD Larsen, Organometallics in Process Chemistry 2004 Springer Verlag, in I. Tsuji, Palladium Reagents and Catalysts 2004 Wiley, and in M. Beller, C. Bolm, Transition Metals for Organic Synthesis 2004 VCH-Wiley. Further suitable synthesis methods are described in Chem.Rev. 2006, 106, 2651; Platinum Metals Review, 2009, 53, 183; Platinum Metals Review 2008, 52, 172 and Acc.Chem.Res. 2008, 41, 1486. ​​In particular, pyrazoles of formula R3-B (OR =Br, I) can be prepared by Sonogashira or Suzuki coupling to form pyrazoles of formula R3-B (OR =Br, I) ... b )(OR c )(wherein, R b and R c The radicals are independently, for example, hydrogen, (C1-C4)-alkyl, or R b and R c When the radicals are bonded to each other, they are collectively ethylene or propylene, and 3 However, further compounds of the invention can be prepared which are defined, for example, as (C1-C6)-alkyl, (C2-C3)-alkenyl, (C2-C3)-alkynyl, (C3-C6)-cycloalkyl, especially cyclopropyl or (C3-C6)-halocycloalkyl.

[0080] Next, a further method for synthesizing the hydroxypyrazole of the general formula (III-a) will be described.

[0081] Scheme 8 first shows the synthesis of compounds of general formula (XVIII) by N-arylation of protected 3-hydroxypyrazoles of general formula (XVI) with aryl halides (XVII) in the presence of a copper halide, such as copper(I) iodide. The reaction is preferably carried out in a suitable solvent, such as acetonitrile or N,N-dimethylformamide, in the presence of a base, such as triethylamine or cesium carbonate, at a temperature range of 0° C. to 120° C. Compounds of general formula (XVI) can be prepared by or in analogy with methods known to those skilled in the art (e.g., Chem.Med.Chem. 2015, 10, 1184-1199). The "X" radical is, for example, chlorine, bromine or iodine. 5-iodopyrazoles of general formula (XIX) are then synthesized by reacting compounds of general formula (XVIII) in the presence of a base, such as lithium diisopropylamide and iodine. The reaction is preferably carried out at a temperature range of -78°C to -60°C in a suitable solvent such as diethyl ether and tetrahydrofuran (see Scheme 8). [ka]

[0082] Said iodopyrazoles of general formula (XIX) can then be used to prepare 3-hydroxypyrazoles of general formula (III-a) (Scheme 9). Thus, for example, compounds of formula (XIX) can be prepared by reacting in a suitable solvent with the reagent MA and an appropriate amount of a transition metal catalyst, in particular a palladium catalyst such as palladium diacetate or bis(triphenylphosphine)palladium(II) dichloride, or a nickel catalyst, for example nickel(II) acetylacetonate or bis(triphenylphosphine)nickel(II) chloride, preferably in an organic solvent such as 1,2-dimethoxyethane at elevated temperature, to give compounds of general formula (XX), which can be converted to hydroxypyrazoles of general formula (III-a) after removal of the protecting groups. The "M" radical can be, for example, B(OR b )(OR c ) (where R b and Rc The radicals are independently, for example, hydrogen or (C1-C4)-alkyl, or R b and R c When the radicals are bonded together, they are collectively ethylene or propylene (Scheme 9). [ka]

[0083] Alternatively, compounds of the invention of formula (Ic) can also be prepared in three steps from 5-aminopyrazoles of general formula XXI as shown in Scheme 10. [ka]

[0084] 5-Aminopyrazoles of general formula (XXII) can be prepared by alkylating compounds of general formula (XXI) with α-halocarboxylic acid esters of general formula (IV) in the presence of a base or similarly by methods known to those skilled in the art (see Scheme 10). The base can be an alkali metal (e.g., lithium, sodium, potassium or cesium) carbonate, and the reaction is preferably carried out in a suitable solvent, e.g., dichloromethane, acetonitrile, N,N-dimethylformamide or ethyl acetate, at a temperature range of room temperature to 150°C. Subsequently, as also shown in Scheme 10, 5-halopyrazoles of general formula (XXIII) are prepared by diazotization of 5-aminopyrazoles of general formula (XXII) by reaction with conventional organic or inorganic nitriles, such as 1,1-dimethylethylnitrile, tert-butylnitrile or isoamylnitrile, in the presence of copper(I) bromide and / or copper(II) bromide, copper(I) chloride and / or copper(II) chloride, or in the presence of copper(I) iodide or elemental iodine. The reaction is preferably carried out in a suitable solvent, such as dichloromethane, acetonitrile, N,N-dimethylformamide or N,N-dimethylacetamide, at a temperature range of 0° C. to 120° C. The "Y" radical of the 5-halopyrazoles of general formula (XXIII) is, for example, chlorine, bromine or iodine. The subsequent conversion to compounds of formula (Ic) is carried out by reaction of 5-halopyrazoles of general formula (XXIII) with the (hetaryl)aryl derivative AM in a suitable solvent, preferably at elevated temperature in an organic solvent, such as 1,2-bimethoxyethane, with the addition of a suitable amount of a transition metal catalyst, in particular a palladium catalyst, such as palladium diacetate or bis(triphenylphosphine)palladium(II) dichloride, or a nickel catalyst, such as nickel(II) acetylacetonate or bis(triphenylphosphine)nickel(II) chloride, where the "M" radical is, for example, Mg-Hal, Zn-Hal, Sn((C1-C4)alkyl)3, lithium, copper or B(OR b )(OR c ), where R b and R cThe radicals are independently, for example, hydrogen, (C1-C4)-alkyl, or R b and R c When the radicals are bonded to each other, they collectively are ethylene or propylene.

[0085] The compounds of formula (I) (and / or salts thereof) according to the present invention, hereinafter collectively referred to as "compounds of the present invention", have excellent herbicidal activity against a broad spectrum of economically important annual harmful monocotyledonous and dicotyledonous plants.

[0086] Therefore, the present invention also provides a method for controlling undesirable plants or regulating plant growth, preferably in plant crops, in which one or more compounds of the present invention are applied to plants (e.g., harmful plants, such as monocotyledonous or dicotyledonous weeds or undesirable crop plants), seeds (e.g., grains, seeds, or vegetative propagules, such as tubers or shoot parts with buds), or areas where plants grow (e.g., areas under cultivation). The compounds of the present invention can be deployed, for example, before sowing (if appropriate, also by mixing into the soil), before emergence or after emergence. Specific examples of some representatives of monocotyledonous and dicotyledonous weed flora that can be controlled by the compounds of the present invention are as follows, but the list is not intended to impose restrictions on specific species.

[0087] Genera of pest monocotyledonous plants: Aegilops, Agropyron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrosti s), Eriochloa, Festuca, Fimbristylis, Heteranthera, Imperata, Ischaemum, Leptochloa, Lolium, Monochoria, Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum.

[0088] Dicotyledonous weed genera: Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, podium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Hibiscus, Ipomoea, Kochia, Lamium ), Lepidium, Lindernia, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, R. orippa), Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica,Veronica, Viola, Xanthium.

[0089] Preemergence application of the compounds of this invention to the soil surface will either completely prevent weed seedlings from emerging or will allow the weeds to grow until they reach the cotyledon stage and then cease growth.

[0090] If the active ingredient is applied to the green parts of the plants by the post-emergence method, growth stops after treatment and the harmful plants either remain in the growth stage at the time of application or they die completely after a certain time, so that in this way competition by harmful weeds for the crop plants is very quickly and persistently eliminated.

[0091] The compounds of the invention are selective for crops of useful plants and can also be used as non-selective herbicides.

[0092] Due to their herbicidal and plant growth regulating properties, the active ingredients can also be used to control harmful plants in crops of genetically modified plants that are known or have not yet been developed.In general, transgenic plants are characterized by particularly advantageous properties, such as resistance to certain active ingredients used in the agrochemical industry, especially to certain herbicides, resistance to plant diseases or plant pathogens, such as certain insects or microorganisms, such as fungi, bacteria or viruses.Other specific properties relate to the harvested material, for example, in terms of quantity, quality, storability, composition and specific components.For example, transgenic plants with high starch content or altered starch quality, or transgenic plants with different fatty acid compositions in the harvested material are known.A further specific property is resistance or resistance to abiotic stress factors, such as heat, cold, drought, salinity and UV light.

[0093] The use of the compounds of the invention of formula (I) or salts thereof in economically important transgenic crops of useful and ornamental plants is preferred.

[0094] The compounds of formula (I) can be used as herbicides in crops of useful plants which are tolerant, or have been made tolerant by genetic engineering, to the phytotoxic effects of herbicides.

[0095] Conventional methods for producing new plants with modified properties compared to existing plants include, for example, conventional cultivation methods and the generation of mutants. Alternatively, new plants with modified properties can be generated with the aid of recombinant methods (see, for example, EP0221044, EP0131624). Described are, for example, the genetic modification of crop plants in order to modify the starch synthesized in the plant (e.g. WO92 / 011376A, WO92 / 014827A, WO91 / 019806A), transgenic crop plants which are resistant to specific herbicides of the glufosinate type (e.g. EP0242236A, EP0242246A) or glyphosate type (WO92 / 000377A) or sulfonylurea type (EP0257993A, US 5,013,659) through "gene stacking" or to combinations or mixtures of these herbicides, for example those manufactured under the trade name or name Optimum TM GAT TM transgenic crop plants such as corn or soybean with glyphosate ALS resistance; Transgenic crop plants, such as cotton (EP0142924A, EP0193259A), capable of producing Bacillus thuringiensis toxins (Bt toxins) that render the plants resistant to certain pests; Transgenic crop plants with altered fatty acid composition (WO91 / 013972A), Genetically modified crop plants with novel components or secondary metabolites, e.g. novel phytoalexins, which result in increased disease resistance (EP0309862A, EP0464461A); Genetically modified plants with reduced photorespiration resulting in higher yields and greater stress tolerance (EP0305398A); · Transgenic crop plants producing proteins of pharmaceutical or diagnostic importance ("molecular farming"); Transgenic crop plants characterized by higher yields or better quality, For example, transgenic crop plants distinguished by combinations of novel traits ("gene stacking") as described above.

[0096] Numerous molecular biological techniques are known in principle that can be used to produce new transgenic plants with modified properties; see, for example, I. Potrykus and G. Spangenberg (eds.), Gene Transfer to Plants, Springer Lab Manual (1995), Springer Verlag Berlin, Heidelberg or Christou, Trends in Plant Science 1 (1996) 423-431.

[0097] For such genetic manipulation, nucleic acid molecules that allow recombinant mutagenesis or sequence modification of DNA sequences can be introduced into plasmids. Standard methods can be used, for example, to perform base exchanges, remove partial sequences, or add natural or synthetic sequences. Adapters or linkers can be added to DNA fragments to allow them to join together. See, for example, Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, or Winnacker "Gene und Klone" [Genes and Clones], VCH Weinheim 2nd ed. 1996.

[0098] For example, the generation of plant cells with reduced activity of a gene product can be achieved by expressing at least one corresponding sense RNA, antisense RNA to achieve a cosuppression effect, or by expressing at least one appropriately constructed ribozyme that specifically cleaves the transcript of said gene product. For this purpose, it is possible to use DNA molecules that first include the entire coding sequence of the gene product, including any adjacent sequences that may be present, and DNA molecules that include only parts of the coding sequence, in which case these parts must be long enough to have an antisense effect in the cell. It is also possible to use DNA sequences that have a high degree of homology with the coding sequence of the gene product, but are not completely identical to them.

[0099] When expressing nucleic acid molecules in plants, the synthesized protein can be localized in any desired compartment of plant cells.However, to achieve localization in a specific compartment, it is possible to, for example, link the coding region to a DNA sequence that ensures localization in a specific compartment.Such sequences are known to those skilled in the art (see, for example, Braun et al., EMBO J.11 (1992), 3219-3227; Wolter et al., Proc.Natl.Acad.Sci.USA 85 (1988), 846-850; Sonnewald et al., Plant J.1 (1991), 95-106).Nucleic acid molecules can also be expressed in organelles of plant cells.

[0100] Transgenic plant cells can be regenerated by known techniques to give whole plants. In principle, the transgenic plants can be of any desired plant species, i.e. monocotyledonous as well as dicotyledonous plants. In this way, transgenic plants can be obtained whose properties are altered by overexpression, suppression or inhibition of a homologous (=natural) gene or gene sequence, or by expression of a heterologous (=foreign) gene or gene sequence.

[0101] The compounds (I) of the invention can be preferably used in transgenic crops which are tolerant to growth regulators, such as 2,4-D, dicamba, or herbicides which inhibit essential plant enzymes, such as acetolactate synthase (ALS), EPSP synthase, glutamine synthase (GS) or hydroxyphenylpyruvate dioxygenase (HPPD), or herbicides from the group of sulfonylureas, glyphosate, glufosinate or benzoylisoxazoles and similar active ingredients, or any desired combination of these active ingredients.

[0102] The compounds of the present invention can be particularly preferably used in transgenic crop plants that are tolerant to the combination of glyphosate and glufosinate, glyphosate and sulfonylurea or imidazolinone.Very particularly preferably, the compounds of the present invention can be used in transgenic crop plants such as corn or soybean, for example, with the trade name or designation OptimumTM GATTM (glyphosate ALS tolerance).

[0103] When the active ingredients of the invention are used in transgenic crops, not only do the effects against harmful plants observed in other crops occur, but also frequently effects specific to the application in the particular transgenic crop, such as modified or specifically broadened spectrum of weeds that can be controlled, altered application rates that can be used for application, preferably good combinability with herbicides to which the transgenic crop is tolerant, and effects influencing the growth and yield of the transgenic crop plants.

[0104] The present invention therefore also relates to the use of the inventive compounds of formula (I) as herbicides for controlling harmful plants in transgenic crop plants.

[0105] The compounds of the present invention can be applied in the form of wettable powders (dusts), emulsifiable concentrates, sprayable solutions, dusts or granules in the usual formulations.Thus, the present invention also provides herbicidal and plant growth regulating compositions comprising the compounds of the present invention.

[0106] The compounds of the present invention can be formulated in various ways according to the biological and / or physicochemical parameters required.Possible formulations include, for example, wettable powders (WP), water-soluble powders (SP), water-soluble concentrates, emulsifiable concentrates (EC), emulsions (EW), such as aqueous emulsions and oil emulsions, sprayable solutions, suspension concentrates (SC), oil-based or aqueous dispersions, oil-fat mixtures, capsule suspension concentrates (CS), dust concentrates (DP), dressings, granules for spraying and soil application, granules in the form of microgranules (GR), spray granules, absorbent granules and adsorbent granules, water-dispersible granules (WG), water-soluble granules (SG), ULV formulations, microcapsules and waxes. These individual formulation types are known in principle and are described, for example, in Winnacker-Kuechler, "Chemische Technologie" [Chemical Technology], Vol. 7, C. Hanser Verlag Munich, 4th edition 1986, Wade van Valkenburg, "Pesticide Formulations", Marcel Dekker, NY, 1973, K. Martens, "Spray Drying" Handbook, 3rd edition, 1979, G. Goodwin Ltd. London.

[0107] The necessary formulation auxiliaries, such as inert materials, surfactants, solvents and further additives, are likewise known and are described, for example, in Watkins, "Handbook of Insecticide Dust Diluents and Carriers", 2nd ed., Darland Books, Caldwell NJ, HvOlphen, "Introduction to Clay Colloid Chemistry", 2nd ed., J. Wiley & Sons, NY, C. Marsden, "Solvents Guide", 2nd ed., Interscience, NY 1963, McCutcheon's "Detergents and Emulsifiers Annual", MC Publ. Corp., Ridgewood NJ, Sisley and Wood, "Encyclopedia of Surface Active Agents", Chem. Publ. Co. Inc., NY 1964, Schoenfeldt, "Grenzflaechenaktive Aethylenoxidaddukte" [Interface-active ethylene oxide adducts], Wiss. Verlagsgesell., Stuttgart 1976, Winnacker-Kuechler, "Chemische Technologie" [Chemical Technology], Volume 7, C. Hanser Verlag Munich, 4th edition, 1986.

[0108] Based on these formulations, it is also possible to prepare combinations with other active ingredients, such as insecticides, acaricides, herbicides, fungicides, as well as safeners, fertilizers and / or growth regulators, for example in the form of finished formulations or as tank mixes.

[0109] The combination partner useful for the compound of the present invention in mixed formulation or tank mix is ​​known active ingredient, for example, based on the inhibition of acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvylshikimate-3-phosphate synthase, glutamine synthetase, p-hydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II or protoporphyrinogen oxidase, as known from, for example, Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 16th edition, The British Crop Protection Council and Royal Soc.of Chemistry, 2006 and the documents cited therein.Known herbicides or plant growth regulators that can be combined with the compound of the present invention are, for example, the following, where the active ingredient is designated either by their "common name" or chemical name or code number according to the International Organization for Standardization (ISO): They always include all use forms, such as acids, salts, esters, and also all isomeric forms, such as stereoisomers and optical isomers, even if not explicitly mentioned.

[0110] Useful combination partners for the compounds of general formula (I) in mixed formulations or tank mixes are known active ingredients based on, for example, the inhibition of acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvylshikimate-3-phosphate synthase, glutamine synthetase, p-hydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II or protoporphyrinogen oxidase or their action as plant growth regulators, as known, for example, from Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 14th Edition, The British Crop Protection Council and Royal Soc. of Chemistry, 2006 and the references cited therein.

[0111] Examples of known herbicides or plant growth regulators which can be combined with the compounds of general formula (I) include the following active ingredients (where the compounds are designated by their "common name" or chemical name or code number according to the International Organization for Standardization (ISO)), always including all use forms, such as acids, salts, esters and isomers, such as stereoisomers and optical isomers. These include, by way of example, one use form and possibly also several use forms: Acetochlor, Acifluorfen, Acifluorfen-methyl, Acifluorfen-sodium, Aclonifen, Alachlor, Allidochlor, Alloxydim, Alloxydim-sodium, Ametryn, Amicarbazone, Amidochlor, Amidosulfuron, 4-Amino-3-chloro-6-(4-chloro-2-fluoro-3-methylphenyl)-5-fluoropyridine-2-carboxylic acid, Aminocyclopyrachlor, Aminocyclopyrachloro-potassium, Aminocyclopyrachloro-methyl, Aminopyralid, Aminopyralid-dimethylammoniu , aminopyralid-tripromine, amitrole, ammonium sulfamate, anilofos, asulam, asulam-potassium, asulam-sodium, atrazine, azafenidine, azimsulfuron, beflubutamid, (S)-(-)-beflubutamid, beflubutamid-M, benazolin, benazolin-ethyl, benazolin-dimethylammonium, benazolin-potassium, benfluralin, benfuresate, bensulfuron, bensulfuron-methyl, bensulide, bentazone, bentazone-sodium, benzobis(benzo[a]pyridine) Klon, Benzofenap, Bicyclopyrone, Bifenox, Biranaphos, Biranaphos-sodium, Bipyrazone, Bispyribac, Bispyribac-sodium, Bixlozone, Bromacil, Bromacil-lithium, Bromacil-sodium, Bromobutide, Bromophenoxime, Bromoxynil, Bromoxynil butyrate, Bromoxynil-potassium, Bromoxynil heptanoate and Bromoxynil octanoate, Busoxynone, Butachlor, Butafenacil, Butamifos, Butenachlor, Butralin, Butroxydim, Butyryl , cafenstrole, cambendiclor, carbetamide, carfentrazone, carfentrazone-ethyl, chloramben, chloramben-ammonium, chloramben-diolamine, chloramben-methyl, chloramben-methylammonium, chloramben-sodium, chlorbromuron, chlorfenac, chlorfenac-ammonium, chlorfenac-sodium, chlorfenprop, chlorfenprop-methyl, chlorflurenol, chlorflurenol-methyl, chloridazon, chlorimuron,Chlorimuron-ethyl, chlorophthalim, chlorotoluron, chlorsulfuron, chlorthal, chlorthal-dimethyl, chlorthal-monomethyl, cinidon, cinidon-ethyl, cinmethylin, exo-(+)-cinmethylin, i.e. (1R,2S,4S)-4-isopropyl-1-methyl-2-[(2-methylbenzyl)oxy]-7-oxabicyclo[2.2.1]heptane, exo-(-)-cinmethylin, i.e. (1R,2S,4S)-4-isopropyl-1-methyl-2-[(2-methylbenzyl)oxy]-7-oxabicyclo[ 2.2.1] heptane, cinosulfuron, clasifos, clethodim, clodinafop, clodinafop-ethyl, clodinafop-propargyl, clomazone, clomeprop, clopyralid, clopyralid-methyl, clopyralid-olamine, clopyralid-potassium, clopyralid-tripomine, cloransulam, cloransulam-methyl, cumyluron, cyanamide, cyanazine, cycloat, cyclopyranyl, cyclopyrimorate, cyclosulfamuron, cycloxydim, cyc Halofop, cyhalofop-butyl, cyprazine, 2,4-D (and its ammonium, butotyl, butyl, choline, diethylammonium, dimethylammonium, diolamine, doboxyl, dodecylammonium, etexyl, ethyl, 2-ethylhexyl, heptylammonium, isobutyl, isooctyl, isopropyl, isopropylammonium, lithium, meptyl, methyl, potassium, tetradecylammonium, triethylammonium, triisopropanolammonium, trypromine and trolamine ( trolamine salts), 2,4-DB, 2,4-DB-butyl, 2,4-DB-dimethylammonium, 2,4-DB-isooctyl, 2,4-DB-potassium and 2,4-DB-sodium, daimuron (dymron), dalapon, dalapon-calcium, dalapon-magnesium, dalapon-sodium, dazomet, dazomet-sodium, n-decanol, 7-deoxy-D-sedoheptulose, desmedipham, detosyl-pyrazolate (DTP), dicamba and its salts (e.g., dicamba biproamine,Dicamba N,N-bis(3-aminopropyl)methylamine, dicamba butotyl, dicamba choline, dicamba diglycolamine, dicamba dimethylammonium, dicamba diethanolaminemmonium, dicamba diethylammonium, dicamba isopropylammonium, dicamba methyl, dicamba monoethanolamine, dicamba olamine, dicamba potassium, dicamba sodium, dicamba triethanolamine, dichlobenil, 2-( 2,4-Dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, 2-(2,5-dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, dichlorprop, dichlorprop-butotyl, dichlorprop-dimethylammonium, dichlorprop-ethexyl, dichlorprop-ethylammonium, dichlorprop-isoctyl, dichlorprop-methyl, dichlorprop-potassium, dichlorprop-sodium, dichlorprop-P, dichlorprop-P- Dimethylammonium, dichlorprop-P-ethexyl, dichlorprop-P-potassium, dichlorprop-sodium, diclofop, diclofop-methyl, diclofop-P, diclofop-P-methyl, diclosulam, difenzoquat, difenzoquat-methylsulfate (metilsulfate), diflufenican, diflufenzopyr, diflufenzopyr-sodium, dimefuron, dimepiperate, dimethasulfazate, dimethachlor, dimethamethrin, dimethenamid, dimethenamid-P, dimetrasulfuro dinitramine, dinoterb, dinoterb-acetate, diphenamide, diquat, diquat-dibromide, diquat-dichloride, dithiopyr, diuron, DNOC, DNOC-ammonium, DNOC-potassium, DNOC-sodium, endothal, endothal-diammonium, endothal-dipotassium, endothal-disodium, epirifenacil (S-3100), EPTC, esprocarb, ethalfluralin, ethametsulfuron, ethametsulfuron-methyl, ethiozin, ethofumesate, ethoxyfene,Ethoxyfen-ethyl, ethoxysulfuron, etobenzanide, F-5231, i.e., N-[2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-4,5-dihydro-5-oxo-1H-tetrazol-1-yl]-phenyl]ethanesulfonamide, F-7967, i.e., 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione, fenoxaprop, fenoxaprop-P, fenoxaprop-P, Fenoxaprop-ethyl, Fenoxaprop-P-ethyl, Fenoxasulfone, Fenpyrazone, Fenquinotrion, Fentrazamide, Flamprop, Flamprop-isopropyl, Flamprop-methyl, Flamprop-M-isopropyl, Flamprop-M-methyl, Flazasulfuron, Florasulam, Florpyrauxifen, Florpyrauxifen-benzyl, Fluazifop, Fluazifop-butyl, Fluazifop-methyl, Fluazifop-P, Fluazifop-P-butyl, Flucarbazone, Flucarbazo fluphenacetin-sodium, flucetosulfuron, fluchloralin, flufenacet, flufenpyr, flufenpyr-ethyl, flumetsulam, flumiclorac, flumiclorac-pentyl, flumioxazin, fluometuron, flurenol, flurenol-butyl, dimethylammonium and methyl, fluoroglycofen, fluoroglycofen-ethyl, flupropanate, flupropanate-sodium, flupyrsulfuron, flupyrsulfuron-methyl, flupyrsulfuron-methyl-sodium, fluridone, flurochloridone , Fluroxypyr, Fluroxypyr-butomethyl, Fluroxypyr-meptyl, Flurtamone, Fluthiacet, Fluthiacet-methyl, Fomesafen, Fomesafen-sodium, Foramsulfuron, Foramsulfuron-sodium, Fosamine, Fosamine-ammonium, Glufosinate, Glufosinate-ammonium, Glufosinate-sodium, L-Glufosinate-ammonium, L-Glufosinate-sodium, Glufosinate-P-sodium, Glufosinate-P-ammonium, Glyphosate, Glyphosate-ammonium,Glyphosate-isopropylammonium, glyphosate-diammonium, glyphosate-dimethylammonium, glyphosate-potassium, glyphosate-sodium, glyphosate-sesquisodium and glyphosate-trimesium, H-9201, i.e., O-(2,4-dimethyl-6-nitrophenyl)-O-ethyl isopropyl phosphoramidothioate, haloxifen, haloxifen-methyl, halosafen, halosulfuron, halosulfuron-methyl, haloxyfop, haloxyfop-P, haloxyfop-ethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop-methyl, haloxyfop-P-methyl, haloxyfop-sodium, hexazinone, HNPC-A8169, i.e., prop-2-yn-1-yl(2S)-2-{3-[(5-tetramethylphenyl)-2-propan-1-yl(2S)-2-(3-[(5-tetramethylphenyl)-2-propan-1-yl ...)-2-propan-1-yl(2S)-2-(3-[(5-tetramethylphenyl)-2-propan-1-yl)-2-propan-1-yl)-2-propan-1-yl(2S)-2-(3-[(5-tetramethylphenyl)-2-propan-1-yl)-2-propan-1-yl)-2-propan rt-Butylpyridin-2-yl)oxy]phenoxy}propanoate, HW-02, i.e., 1-(dimethoxyphosphoryl)ethyl (2,4-dichlorophenoxy)acetate, hydantocidin, imazamethabenz, imazamethabenz-methyl, imazamox, imazamox-ammonium, imazapic, imazapic-ammonium, imazapyr, imazapyr-isopropylammonium, imazaquin, imazaquin-ammonium, imazaquin-methyl, isopropylammonium ... Mazethapyr, imazethapyr-ammonium, imazosulfuron, indanofan, indaziflam, iodosulfuron, iodosulfuron-methyl, iodosulfuron-methyl-sodium, ioxynil, ioxynil-lithium, -octanoate, -potassium and -sodium, ipfencarbazone, isoproturon, isouron, isoxaben, isoxaflutole, carbutilate, KUH-043, i.e., 3-({[5-(difluoromethyl)-1 -Methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazole, ketospiradox, ketospiradox-potassium, lactofen, lenacil, linuron, MCPA, MCPA-butotyl, -butyl, -dimethylammonium, -diolamine, -2-ethylhexyl, -ethyl, -isobutyl, -isooctyl, -isopropyl, -isopropylammonium, -methyl,-olamine, -potassium, -sodium and -trolamine, MCPB, MCPB-methyl, -ethyl and -sodium, mecoprop, mecoprop-butotyl, mecoprop-dimethylammonium, mecoprop-diolamine, mecoprop-ethexyl, mecoprop-ethadyl, mecoprop-isoctyl, l), mecoprop-methyl, mecoprop-potassium, mecoprop-sodium, and mecoprop-trolamine, mecoprop-P, mecoprop-P-butotyl, -dimethylammonium, -2-ethylhexyl and potassium, mefenacet, mefluidide, mefluidide-diolamine, mefluidide-potassium, mesosulfuron, mesosulfuron-methyl, mesosulfuron-sodium, mesotrione, methabenzthiazuron, metam, metamifop, metamitron, metazachlor, metazosulfuron, methabenzthiazuron, methio Methiopyrsulfuron, methiozolin, methyl isothiocyanate, metobromuron, metolachlor, S-metolachlor, metoslam, methoxron, metribuzin, metsulfuron, metsulfuron-methyl, molinate, monolinuron, monosulfuron, monosulfuron-methyl, MT-5950, i.e., N-[3-chloro-4-(1-methylethyl)-phenyl]-2-methylpentanamide, NGGC-011, napropamide, NC-310, i.e., 4-(2,4-dichlorobenzoyl)-1-methylphenyl, ethyl-5-benzyloxypyrazole, NC-656, i.e., 3-[(isopropylsulfonyl)methyl]-N-(5-methyl-1,3,4-oxadiazol-2-yl)-5-(trifluoromethyl)[1,2,4]triazolo-[4,3-a]pyridine-8-carboxamide, nebulon, nicosulfuron, nonanoic acid (pelargonic acid), norflurazon, oleic acid (fatty acid), orbencarb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon, oxasulfuron, oxaziclomefon, oxyfluorfen, para quat, paraquat-dichloride, paraquat-dimethyl sulfate, pebulate, pendimethalin, penoxsulam, pentachlorophenol, pentoxazone, petoxamide, petroleum, phenmedipham, phenmedipham-ethyl, picloram, picloram-dimethylammonium, picloram-ethexyl, picloram-isoctyl, picloram-methyl, picloram-olamine, picloram-potassium, picloram-triethylammonium, picloram-tryplomine, picloram-trolamine, picolinafen, pinoxaden,Piperophos, pretilachlor, primisulfuron, primisulfuron-methyl, prodiamine, propoxydim, prometon, prometryn, propachlor, propanil, propaquizafop, propazine, propham, propisochlor, propoxycarbazone, propoxycarbazone-sodium, propyrisulfuron, propyzamide, prosulfocarb, prosulfuron, pyraclonil, pyraflufen, pyraflufen-ethyl, pyrasulfotole, pyrazolinate (pyrazolate), pyrazosulfuron, pyrazosulfuron-ethyl, pyrazoxyfen, pyribambenz, pyribambenz-isopropyl, pyribambenz-propyl, pyribenzoxim, pyributicarb, pyridafol, pyridate, pyriftalid, pyriminobac, pyriminobac-methyl, pyrimisulfan, pyrithiobac , pyrithiobac-sodium, pyroxasulfone, pyroxsulam, quinclorac, quinclorac-dimethylammonium, quinclorac-methyl, quinmerac, quinoclamine, quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, QYM201, i.e., 1-{2-chloro-3-[(3-cyclopropyl-5-hydroxy-1-methyl- 1H-pyrazol-4-yl)carbonyl]-6-(trifluoromethyl)phenyl}piperidin-2-one, rimsulfuron, saflufenacil, sethoxydim, siduron, simazine, simetryn, SL-261, sulcotrione, sulfentrazone, sulfometuron, sulfometuron-methyl, sulfosulfuron, SYP-249, i.e., 1-ethoxy-3-methyl-1-oxobut-3-en-2-yl 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate, SYP-300, i.e. 1-[7-fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-3-propyl-2-thioxoimidazolidine-4,5-dione, 2,3,6-TBA, TCA (trichloroacetic acid) and its salts, e.g. TCA-ammonium, TCA-calcium, TCA-ethyl, TCA-magnesium, TCA-sodium, tebuthiuron, tefuryltrione,Tembotrione, tepraloxydim, terbacil, terbucarb, terbumeton, terbuthylazine, terbutryn, tetflupyrolimet, saxtomin, thenylchlor, thiazopyr, thiencarbazone, thiencarbazone-methyl, thifensulfuron, thifensulfuron-methyl, thiobencarb, thiaphenacyl, torpiralate, topramezone, tralkoxydim, triafamone, triallate, triasulfuron, triaziflam, tribenuron, tribenuron-methyl, triclopyr, triclopyr-butotyl, triclopyr-choline, triclopyr-ethyl, triclopyr-triethylammonium, trietazine, trifloxysulfuron, trifloxysulfuron-sodium, trifludimoxazine, trifluralin, triflusulfuron, triflusulfuron-methyl, tritosulfuron, urea sulfate (urea sulfate) sulfate), vernolate, XDE-848, ZJ-0862, i.e., 3,4-dichloro-N-{2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}aniline, 3-(2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydropyrimidin-1(2H)-yl)phenyl)-5-methyl-4,5-dihydroisoxazole-5-carboxylic acid ethyl ester, ethyl-[(3-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenoxy}pyridin-2-yl)oxy]acetate, 3-chloro-2-[3-(difluoromethyl)isoxazolyl-5-yl]phenyl-5-chloropyrimidin-2-yl ether, 2-(3,4-dimethoxyphenyl)-4-[(2-hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-6-methylpyridazin-3(2H)-one, 2-({2-[(2-methoxyethoxy)methyl]-6-methylpyridin-3-yl}carbonyl)cyclohexane-1,3-dione, (5-hydroxy-1-methyl-1H-pyrazol-4-yl)(3,3,4-trimethyl-1,1-dioxide-2,3-dihydro-1-benzothiophen-5-yl)methanone,1-Methyl-4-[(3,3,4-trimethyl-1,1-dioxide-2,3-dihydro-1-benzothiophen-5-yl)carbonyl]-1H-pyrazol-5-yl propane-1-sulfonate; 4-{2-chloro-3-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]-4-(methylsulfonyl)benzoyl}-1-methyl-1H-pyrazol-5-yl 1,3-dimethyl-1H-pyrazole-4-carboxylate; Cyanomethyl 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylate; Prop-2-yn-1-yl 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylate, 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-methyl carboxylate, 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylic acid, 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-benzyl carboxylate, 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-ethyl carboxylate, 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine -2-carboxylate methyl, 6-(1-acetyl-7-fluoro-1H-indol-6-yl)-4-amino-3-chloro-5-fluoropyridine-2-carboxylate methyl, 4-amino-3-chloro-6-[1-(2,2-dimethylpropanoyl)-7-fluoro-1H-indol-6-yl]-5-fluoropyridine-2-carboxylate methyl, 4-amino-3-chloro-5-fluoro-6-[7-fluoro-1-(methoxyacetyl)-1H-indol-6-yl]pyridine-2-carboxylate methyl, 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylate potassium, 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylate sodium,4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylate butyl, 4-hydroxy-1-methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, 3-(5-tert-butyl-1,2-oxazol-3-yl)-4-hydroxy-1-methylimidazolidin-2-one, 3-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-4-hydroxy-1-methylimidazolidin-2-one, 4-hydroxy-1 -Methoxy-5-methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, 6-[(2-hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1,5-dimethyl-3-(2-methylphenyl)quinazoline-2,4(1H,3H)-dione, 3-(2,6-dimethylphenyl)-6-[(2-hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1-methylquinazoline-2,4(1H,3H)-dione, 2-[2-chloro-4-(methylsulfonyl) nyl)-3-(morpholin-4-ylmethyl)benzoyl]-3-hydroxycyclohex-2-en-1-one, 1-(2-carboxyethyl)-4-(pyrimidin-2-yl)pyridazin-1-ium salts (with a suitable anion, such as chloride, acetate or trifluoroacetate), 1-(2-carboxyethyl)-4-(pyridazin-3-yl)pyridazin-1-ium salts (with a suitable anion, such as chloride, acetate or trifluoroacetate), 4-(pyrimidin-2-yl)- 1-(2-sulfoethyl)pyridazin-1-ium salts (with a suitable anion, for example, chloride, acetate or trifluoroacetate), 4-(pyridazin-3-yl)-1-(2-sulfoethyl)pyridazin-1-ium salts (with a suitable anion, for example, chloride, acetate or trifluoroacetate), 1-(2-carboxyethyl)-4-(1,3-thiazol-2-yl)pyridazin-1-ium salts (with a suitable anion, for example, chloride, acetate or trifluoroacetate),1-(2-carboxyethyl)-4-(1,3-thiazol-2-yl)pyridazin-1-ium salts (with appropriate anions, e.g., chloride, acetate, or trifluoroacetate), methyl (2R)-2-{[(E)-({2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}methylidene)amino]oxy}propanoate, (E)-2-(trifluoromethyl)benzaldehyde O-{2, ,6-Bis[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoyl}oxime, 2-fluoro-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-[(R)-propylsulfinyl]-4-(trifluoromethyl)benzamide, (2R)-2-[(4-amino-3,5-dichloro-6-fluoro-2-pyridyl)oxy]propanecarboxylic acid, 2-ethoxy-2-oxoethyl 1-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenoxy}cyclopropanecarboxylate, 2-methoxy-2-oxoethyl 1-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenoxy}cyclopropanecarboxylate, {[(1-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenoxy}cyclopropyl)carbonyl]oxy}acetic acid.

[0112] Abscisic acid and related analogues [e.g., (2Z,4E)-5-[6-ethynyl-1-hydroxy-2,6-dimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoic acid, methyl (2Z,4E)-5-[6-ethynyl-1-hydroxy-2,6-dimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoate, (2Z,4E)-3-ethyl-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoate, (2E,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-(trifluoromethyl)penta-2,4-dienoic acid, methyl (2E,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-(trifluoromethyl)penta-2,4-dienoate, (2Z,4E)-5-(2-hydroxy-1,3-dimethyl-5-oxobicyclo[4.1.0]hept-3-en-2-yl)-3-methylpenta-2,4-dienoic acid], acibenzolar, acibenzolar-S-methyl, S-adenosylhomocysteine, allantoin, 2-aminoethoxyvinylglycine (AVG), aminooxyacetic acid and related esters [e.g., (isopropylidene)aminooxyacetic acid 2-(methoxy)-2-oxoethyl ester, (isopropylidene)aminooxyacetic acid 2-(hexyloxy)-2-oxoethyl ester, (cyclohexylidene)aminooxyacetic acid-2-(isopropyloxy)-2-oxoethyl ester], 1-aminocycloprop-1-yl carboxylic acid N-methyl-1-aminocyclopropyl-1-carboxylic acid, 1-aminocyclopropyl-1-carboxamide, substituted 1-aminocyclopropyl-1-carboxylic acid derivatives as described in DE 3335514, EP 30287, DE 2906507 or US 5123951, 1-aminocyclopropyl-1-hydroxamic acid, 5-aminolevulinic acid, ancymidol, 6-benzylaminopurine, bikinin, brassinolide, brassinolide-ethyl, L-canarine, catechol and catechols (e.g., (2S,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol), chitooligosaccharides (CO; CO differs from LCOs in that it lacks the fatty acid side chains characteristic of LCO. CO, sometimes called N-acetylchitooligosaccharides, is composed of GlcNAc residues, but is not bound to the chitin molecule [(CH. 13 No. 5) n , CAS No. 1398-61-4] and chitosan molecule [(C 11 No. 4) n, CAS No. 9012-76-4]), chitin-like compounds, chlormequat chloride, cloprop, cyclanilide, 3-(cycloprop-1-enyl)propionic acid, 1-[2-(4-cyano-3,5-dicyclopropylphenyl)acetamido]cyclohexanecarboxylic acid, 1-[2-(4-cyano-3-cyclopropylphenyl)acetamido]cyclohexanecarboxylic acid, 1-cyclopropenylmethanol, daminozide, dazomet, dazomet-sodium, n-decanol, dikegluc, dikegluc-sodium, endothal, endothal-dipotassium, -disodium, and mono(N,N-dimethylalkylammonium), ethephon, 1- Ethylcyclopropene, flumetraline, flurenol, flurenol-butyl, flurenol-methyl, flurprimidol, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid (IAA), 4-indol-3-ylbutyric acid, isoprothiolane, probenazole, jasmonic acid, jasmone esters or other derivatives (e.g., jasmonate methyl ester, jasmonate ethyl ester), lipo-chitooligosaccharides (LCOs), also called symbiotic nodulation signals (Nod or Nod factors) or Myc factors, consist of an oligosaccharide backbone consisting of β-1,4-linked N-acetyl-D-glucosamine units ("GlcNAc") and N-linked fatty acid side chains condensed at the non-reducing end.As can be inferred from the literature, LCOs differ in the number of GlcNAc units in the backbone structure, the length and saturation of the fatty acid chains, and the substitution of reducing and non-reducing sugar units), linoleic acid or its derivatives, linolenic acid or its derivatives, maleic acid hydrazide, mepiquat chloride, mepiquat pentaborate, 1-methylcyclopropene, 3-methylcyclopropene, methoxyvinylglycine (MVG), 3'-methylabscisic acid, 1-(4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydrofuran, 1-methyl-2 ... (3E,3αR,8βS)-3-({[(2R)-4-methyl-5-oxo-2,5-dihydrofuran-2-yl]oxy}methylene)-3,3α,4,8β-tetrahydro-2H-indeno[1,2-b]furan-2-one and related lactones as outlined in EP 2248421, 2-(1-naphthyl)acetamide, 1-naphthylacetic acid, 2-naphthyloxyacetic acid, nitrophenoxide mixtures, 4-oxo -4[(2-phenylethyl)amino]butyric acid, paclobutrazol, 4-phenylbutyric acid and their salts (e.g., sodium 4-phenylbutanoate, potassium 4-phenylbutanoate), phenylalanine, N-phenylphthalamic acid, prohexadione, prohexadione-calcium, 1-n-propylcyclopropene, putrescine, prohydrojasmone, rhizobitoxin, salicylic acid and methyl salicylate, sarcosine, sodium cycloprop-1-en-1-yl acetate, cycloprop Sodium per-2-en-1-yl acetate, sodium 3-(cycloprop-2-en-1-yl)propanoate, sodium 3-(cycloprop-1-en-1-yl)propanoate, sidefungin, spermidine, spermine, strigolactone, tecnazene, thidiazuron, triacontanol, trinexapac, trinexapac-ethyl, tryptophan, tsitodef, uniconazole, uniconazole-P, 2-fluoro-N-(3-methoxyphenyl)-9H-purin-6-amine.

[0113] The safener is preferably selected from the group consisting of: S1) A compound of formula (S1) [ka] where the symbols and subscripts are defined as follows: n A is a natural number from 0 to 5, preferably from 0 to 3, R A 1 is halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, nitro or (C1-C4)-haloalkyl, W A is an unsubstituted or substituted divalent heterocyclic radical selected from the group of partially unsaturated or aromatic 5-membered heterocycles having 1 to 3 ring heteroatoms selected from the group of N and O, in which at least one nitrogen atom and at most one oxygen atom is present in the ring, preferably (W A 1 )~(W A 5 ) [ka] is a radical from the group m A is either 0 or 1, R A 2 OR A 3 , S.R. A 3 or NR A 3 R A 4or a saturated or unsaturated 3- to 7-membered heterocycle having at least one nitrogen atom and up to three heteroatoms, preferably selected from the group consisting of O and S, which is linked to the carbonyl group in (S1) via a nitrogen atom and which is unsubstituted or substituted with a radical selected from the group consisting of (C1-C4)-alkyl, (C1-C4)-alkoxy or optionally substituted phenyl, preferably of the formula OR A 3 , formula NHR A 4 or a radical of the formula N(CH3)2, in particular of the formula OR A 3 Based on R A 3 is hydrogen or an unsubstituted or substituted aliphatic hydrocarbon radical, preferably having a total of 1 to 18 carbon atoms; R A 4 is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkoxy or substituted or unsubstituted phenyl, R A 5 is H, (C1-C8)-alkyl, (C1-C8)-haloalkyl, (C1-C4)-alkoxy-(C1-C8)-alkyl, cyano or COOR A 9 where R A 9 is hydrogen, (C1-C8)-alkyl, (C1-C8)-haloalkyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, (C1-C6)-hydroxyalkyl, (C3-C 12 )-cycloalkyl or tri-(C1-C4)-alkylsilyl, R A 6 , R A 7 , R A 8 are the same or different and each represents hydrogen, (C1-C8)-alkyl, (C1-C8)-haloalkyl, (C3-C12 )-cycloalkyl, or substituted or unsubstituted phenyl; R A 10 H, (C3-C 12 )-cycloalkyl, substituted or unsubstituted phenyl or substituted or unsubstituted heteroaryl; Preferably: a) Dichlorophenylpyrazoline-3-carboxylic acid type compounds (S1 a ), preferably compounds such as 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazoline-3-carboxylic acid, ethyl 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazoline-3-carboxylate (S1-1) ("mefenpyr-diethyl") and related compounds, which are described in WO-A-91 / 07874, b) Derivatives of dichlorophenylpyrazole carboxylic acid (S1 b ), preferably compounds such as ethyl 1-(2,4-dichlorophenyl)-5-methylpyrazole-3-carboxylate (S1-2), ethyl 1-(2,4-dichlorophenyl)-5-isopropylpyrazole-3-carboxylate (S1-3), ethyl 1-(2,4-dichlorophenyl)-5-(1,1-dimethylethyl)pyrazole-3-carboxylate (S1-4) and related compounds, which are described in EP-A-333131 and EP-A-269806, c) Derivatives of 1,5-diphenylpyrazole-3-carboxylic acid (S1 c ), preferably compounds such as ethyl 1-(2,4-dichlorophenyl)-5-phenylpyrazole-3-carboxylate (S1-5), methyl 1-(2-chlorophenyl)-5-phenylpyrazole-3-carboxylate (S1-6) and related compounds, which are described, for example, in EP-A-268554, d) Triazole carboxylic acid type compounds (S1 d), preferably compounds such as fenchlorazole (-ethyl ester), i.e. ethyl 1-(2,4-dichlorophenyl)-5-trichloromethyl-(1H)-1,2,4-triazole-3-carboxylate (S1-7) and related compounds, which are described in EP-A-174562 and EP-A-346620, e) 5-benzyl-2-isoxazoline-3-carboxylic acid or 5-phenyl-2-isoxazoline-3-carboxylic acid or 5,5-diphenyl-2-isoxazoline-3-carboxylic acid type compounds (S1 e ), preferably compounds such as ethyl 5-(2,4-dichlorobenzyl)-2-isoxazoline-3-carboxylate (S1-8) or ethyl 5-phenyl-2-isoxazoline-3-carboxylate (S1-9) and related compounds, which are described in WO-A-91 / 08202, or 5,5-diphenyl-2-isoxazoline-3-carboxylic acid (S1-10) or ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate (S1-11) ("isoxadifen-ethyl") or n-propyl 5,5-diphenyl-2-isoxazoline-3-carboxylate (S1-12) or ethyl 5-(4-fluorophenyl)-5-phenyl-2-isoxazoline-3-carboxylate (S1-13), which are described in patent application WO-A-95 / 07897, f) Triazolyloxyacetic acid derivative type compounds (S1 f), preferably compounds such as {[1,5-bis(4-chloro-2-fluorophenyl)-1H,2,4-triazol-3-yl]oxy}methyl acetate (S1-14) or {[1,5-bis(4-chloro-2-fluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-15) or {[5-(4-chloro-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}methyl acetate (S1-16) or {[5-(4-chloro-2-fluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}methyl acetate (S1-17) {[1-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-17) or methyl {[1-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate (S1-18) or {[1-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-19) (which are described in patent application WO2021105101).

[0114] S2) Quinoline derivative of formula (S2) [ka] where the symbols and subscripts are defined as follows: R B 1 is halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, nitro or (C1-C4)-haloalkyl, n B is a natural number from 0 to 5, preferably a natural number from 0 to 3, R B 2 OR B 3 , S.R. B 3 or NR B 3 R B 4or a saturated or unsaturated 3- to 7-membered heterocycle having at least one nitrogen atom and up to three heteroatoms, preferably selected from the group O and S, which is linked to the carbonyl group in (S2) via a nitrogen atom and which is unsubstituted or substituted with a radical selected from the group (C1-C4)-alkyl, (C1-C4)-alkoxy or optionally substituted phenyl, preferably of the formula OR B 3 , formula NHR B 4 or a radical of the formula N(CH3)2, in particular of the formula OR B 3 is a radical of R B 3 is hydrogen or an unsubstituted or substituted aliphatic hydrocarbon radical, preferably having a total of 1 to 18 carbon atoms; R B 4 is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkoxy or substituted or unsubstituted phenyl, T B is a (C1 or C2)-alkanediyl chain, which is unsubstituted or substituted by one or two (C1-C4)-alkyl radicals or by [(C1-C3)-alkoxy]carbonyl, Preferably, a) 8-Quinolineoxyacetic acid type compounds (S2 a ), preferably 1-methylhexyl (5-chloro-8-quinolinoxy)acetate ("cloquintocet-mexyl") (S2-1), 1,3-dimethyl-but-1-yl (5-chloro-8-quinolinoxy)acetate (S2-2), (5-chloro-8-quinolinoxy)acetic acid 4-allyloxybutyl (S2-3), (5-chloro-8-quinolinoxy)acetic acid 1-allyloxyprop-2-yl (S2-4), (5-chloro-8-quinolinoxy)ethyl acetate (S2-5), (5-chloro-8-quinolinoxy)methyl acetate (S2-6), (5-chloro-8-quinolinoxy)allyl acetate (S2-7), 2-(2-propylideneiminooxy)-1-ethyl (5-chloro-8-quinolinoxy)acetate (S2-8), 2-oxoprop-1-yl (5-chloro-8-quinolinoxy)acetate (S2-9) and related compounds, which are described in EP-A-86750, EP-A-94349 and EP-A-191736 or EP-A-0492366, and also (5-chloro-8-quinolinoxy)acetic acid (S2-10), its hydrates and salts, for example its lithium, sodium, potassium, calcium, magnesium, aluminium, iron, ammonium, quaternary ammonium, sulfonium or phosphonium salts, which are described in WO-A-2002 / 34048, b) (5-chloro-8-quinolinoxy)malonic acid type compounds (S2 b ), preferably compounds such as diethyl (5-chloro-8-quinolinoxy)malonate, diallyl (5-chloro-8-quinolinoxy)malonate, methylethyl (5-chloro-8-quinolinoxy)malonate and related compounds, which are described in EP-A-0582198.

[0115] S3) Compound of formula (S3) [ka] where the symbols and subscripts are defined as follows: R C 1 is (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C2-C4)-alkenyl, (C2-C4)-haloalkenyl, (C3-C7)-cycloalkyl, preferably dichloromethyl, R C 2 , R C 3are identical or different and are hydrogen, (C1-C4)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C1-C4)-haloalkyl, (C2-C4)-haloalkenyl, (C1-C4)-alkylcarbamoyl-(C1-C4)-alkyl, (C2-C4)-alkenylcarbamoyl-(C1-C4)-alkyl, (C1-C4)-alkoxy-(C1-C4)-alkyl, dioxolanyl-(C1-C4)-alkyl, thiazolyl, furyl, furylalkyl, thienyl, piperidyl, substituted or unsubstituted phenyl or R C 2 and R C 3 together form a substituted or unsubstituted heterocyclic ring, preferably an oxazolidine ring, a thiazolidine ring, a piperidine ring, a morpholine ring, a hexahydropyrimidine ring or a benzoxazine ring, Preferably: Active ingredients of the dichloroacetamide type, which are often used as pre-emergence safeners (soil-acting safeners), e.g. "Dichlormid" (N,N-diallyl-2,2-dichloroacetamide) (S3-1), "R-29148" (3-dichloroacetyl-2,2,5-trimethyl-1,3-oxazolidine) [from Stauffer] (S3-2), "R-28725" (3-dichloroacetyl-2,2-dimethyl-1,3-oxazolidine) [from Stauffer] (S3-3), "Benoxacor" (4-dichloroacetyl-3,4-dihydro-3-methyl-2H-1,4-benzoxazine) (S3-4), "PPG-1292" (N-allyl-N-[(1,3-dioxolan-2-yl)methyl]dichloroacetamide) from PPG Industries (S3-5), "DKA-24" (N-allyl-N-[(allylaminocarbonyl)methyl]dichloroacetamide) [from Sagro-Chem] (S3-6), "AD-67" or "MON 4660" (3-dichloroacetyl-1-oxa-3-azaspiro[4.5]decane) [from Nitrokemia or Monsanto] (S3-7), "TI-35" (1-dichloroacetylazepane) [from TRI-Chemical RT] (S3-8), "diclonon" (dicyclonon) or "BAS145138" or "LAB145138" (S3-9), ((RS)-1-Dichloroacetyl-3,3,8a-trimethylperhydropyrrolo[1,2-a]pyrimidin-6-one) [from BASF], "Furilazol" or "MON13900" ((RS)-3-dichloroacetyl-5-(2-furyl)-2,2-dimethyloxazolidine) (S3-10) and its (R)-isomer (S3-11).

[0116] S4) N-acylsulfonamides of formula (S4) and their salts [ka] where the symbols and subscripts are defined as follows: X D is CH or N, R D 1 is CO-NR D 5 R D 6 or NHCO-R D 7 and R D 2 is halogen, (C1-C4)-haloalkyl, (C1-C4)-haloalkoxy, nitro, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-alkylsulfonyl, (C1-C4)-alkoxycarbonyl or (C1-C4)-alkylcarbonyl, R D 3is hydrogen, (C1-C4)-alkyl, (C2-C4)-alkenyl or (C2-C4)-alkynyl, R D 4 is halogen, nitro, (C-C)-alkyl, (C-C)-haloalkyl, (C-C)-haloalkoxy, (C-C)-cycloalkyl, phenyl, (C-C)-alkoxy, cyano, (C-C)-alkylthio, (C-C)-alkylsulfinyl, (C-C)-alkylsulfonyl, (C-C)-alkoxycarbonyl or (C-C)-alkylcarbonyl, R D 5 is hydrogen, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C5-C6)-cycloalkenyl, phenyl or 3-6 membered heterocyclyl, where the heterocyclyl is selected from the group consisting of nitrogen, oxygen and sulfur. D 4 heteroatoms), in which the last seven radicals mentioned are selected from the group consisting of halogen, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, (C1-C2)-alkylsulfinyl, (C1-C2)-alkylsulfonyl, (C3-C6)-cycloalkyl, (C1-C4)-alkoxycarbonyl, (C1-C4)-alkylcarbonyl and phenyl, and in the case of cyclic radicals are additionally selected from the group consisting of (C1-C4)-alkyl and (C1-C4)-haloalkyl, D is substituted with R D 6 is hydrogen, (C1-C6)-alkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, where the last three mentioned radicals are selected from the group consisting of halogen, hydroxy, (C1-C4)-alkyl, (C1-C4)-alkoxy and (C1-C4)-alkylthio. D is substituted with one or more radicals; or R D 5 and RD 6 together with the nitrogen atom bearing them form a pyrrolidinyl or piperidinyl radical, R D 7 is hydrogen, (C1-C4)-alkylamino, di-(C1-C4)-alkylamino, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, where the last two mentioned radicals are selected from the group consisting of halogen, (C1-C4)-alkoxy, (C1-C6)-haloalkoxy and (C1-C4)-alkylthio and, in the case of cyclic radicals, additionally from the group consisting of (C1-C4)-alkyl and (C1-C4)-haloalkyl, v D is substituted with n D is 0, 1 or 2, m D is either 1 or 2, v D is 0, 1, 2 or 3,

[0117] Among these, N-acylsulfonamide type compounds are preferred, for example, compounds represented by the following formula (S4 a ), which is known, for example, from WO-A-97 / 45016, [ka] During the ceremony, R D 7 is (C1-C6)-alkyl or (C3-C6)-cycloalkyl, where the last two mentioned radicals are selected from the group consisting of halogen, (C1-C4)-alkoxy, (C1-C6)-haloalkoxy and (C1-C4)-alkylthio and, in the case of cyclic radicals, additionally from the group consisting of (C1-C4)-alkyl and (C1-C4)-haloalkyl, v D is substituted with R D 4is halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy or CF3, m D is either 1 or 2, v D is 0, 1, 2 or 3, And also For example, the following formula (S4 b ) acylsulfamoylbenzamides, which are known, for example, from WO-A-99 / 16744, [ka]

[0118] For example, in the formula: R D 5 = cyclopropyl and (R D 4 ) = 2-OMe ("cyprosulfamide", S4-1), R D 5 = cyclopropyl and (R D 4 ) = 5-Cl-2-OMe (S4-2), R D 5 = Ethyl and (R D 4 )=2-OMe(S4-3), R D 5 = isopropyl and (R D 4 ) = 5-Cl-2-OMe (S4-4) and R D 5 = isopropyl and (R D 4 )=2-OMe(S4-5); and The following formula (S4 c ) N-acylsulfamoylphenylurea type compounds, which are known, for example, from EP-A-365484, [ka] During the ceremony, R D 8 and R D 9 are, independently of one another, hydrogen, (C1-C8)-alkyl, (C3-C8)-cycloalkyl, (C3-C6)-alkenyl or (C3-C6)-alkynyl, R D 4 is halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, CF3, m D is either 1 or 2, for example, 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3-methylurea, 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3,3-dimethylurea, 1-[4-(N-4,5-dimethylbenzoylsulfamoyl)phenyl]-3-methylurea.

[0119] S5) Active ingredients (S5) selected from the class of the hydroxyaromatic and aromatic-aliphatic carboxylic acid derivatives, such as, for example, ethyl 3,4,5-triacetoxybenzoate, 3,5-dimethoxy-4-hydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 4-hydroxysalicylic acid, 4-fluorosalicylic acid, 2-hydroxycinnamic acid, 2,4-dichlorocinnamic acid (these are described in WO-A-2004 / 084631, WO-A-2005 / 015994, WO-A-2005 / 016001).

[0120] S6) Active ingredients (S6) selected from the class of 1,2-dihydroquinoxalin-2-ones, for example 1-Methyl-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one, 1-methyl-3-(2-thienyl)-1,2-dihydroquinoxaline-2-thione, 1-(2-aminoethyl)-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one hydrochloride, 1-(2-methylsulfonylaminoethyl)-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one, which are described in WO-A-2005 / 112630.

[0121] S7) Compounds of formula (S7), which are described in WO-A-1998 / 38856, [ka] where the symbols and subscripts are defined as follows: R E 1 , R E 2 are independently halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkyl, (C1-C4)-alkylamino, di-(C1-C4)-alkylamino, nitro, A E COOR E 3 or COSR E 4 and R E 3 , R E 4 are independently hydrogen, (C1-C4)-alkyl, (C2-C6)-alkenyl, (C2-C4)-alkynyl, cyanoalkyl, (C1-C4)-haloalkyl, phenyl, nitrophenyl, benzyl, halobenzyl, pyridinylalkyl and alkylammonium, n E 1 is either 0 or 1, n E 2 , n E 3 independently represent 0, 1 or 2; Preferably, Diphenylmethoxyacetic acid, ethyl diphenylmethoxyacetate, methyl diphenylmethoxyacetate (CAS reg. no. 41858-19-9) (S7-1).

[0122] S8) Compounds of formula (S8), which are described in WO-A-98 / 27049, [ka] [During the ceremony, X F is CH or N, n F X F If =N, it is an integer from 0 to 4, and n F X F When =CH, it is an integer from 0 to 5; R F 1 is halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, nitro, (C1-C4)-alkylthio, (C1-C4)-alkylsulfonyl, (C1-C4)-alkoxycarbonyl, optionally substituted phenyl, optionally substituted phenoxy, R F 2 is hydrogen or (C1-C4)-alkyl, R F 3 is hydrogen, (C1-C8)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl or aryl, in which each of the carbon-containing radicals is unsubstituted or substituted with one or more, preferably up to three, identical or different radicals selected from the group consisting of halogen and alkoxy. or a salt thereof,

[0123] Preferably, in the above formula: X F is CH, n F is an integer from 0 to 2, R F 1 is halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, R F 2 is hydrogen or (C1-C4)-alkyl, R F 3 is hydrogen, (C1-C8)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl or aryl, where each of the carbon-containing radicals is unsubstituted or substituted with one or more, preferably up to three, identical or different radicals selected from the group consisting of halogen and alkoxy. A compound or a salt thereof.

[0124] S9) Active ingredients (S9) selected from the class of 3-(5-tetrazolylcarbonyl)-2-quinolones, for example 1,2-Dihydro-4-hydroxy-1-ethyl-3-(5-tetrazolylcarbonyl)-2-quinolone (CAS reg. no. 219479-18-2), 1,2-dihydro-4-hydroxy-1-methyl-3-(5-tetrazolylcarbonyl)-2-quinolone (CAS Reg. No. 95855-00-8), which are described in WO-A-1999 / 000020.

[0125] S10) Formula (S10 a ) or formula (S10 b ) which are described in WO-A-2007 / 0237190 and WO-A-2007 / 023764. [ka] [During the ceremony, R G 1 is halogen, (C1-C4)-alkyl, methoxy, nitro, cyano, CF3, OCF3, Y G , ZG represent, independently of one another, O or S, n G is an integer from 0 to 4, R G 2 is (C1-C 16 )-alkyl, (C2-C6)-alkenyl, (C3-C6)-cycloalkyl, aryl; benzyl, halobenzyl; R G 3 is hydrogen or (C1-C6)-alkyl.

[0126] S11) Active ingredients of the oxyimino compound type (S11), which are known as seed dressing compositions, e.g. "Oxabetrinil" ((Z)-1,3-dioxolan-2-yl-methoxyimino(phenyl)acetonitrile) (S11-1), a known seed dressing safener for foxtail millet / sorghum against metolachlor injury, "Fluxofenim" (1-(4-chlorophenyl)-2,2,2-trifluoro-1-ethanone O-(1,3-dioxolan-2-ylmethyl)oxime) (S11-2), a known seed dressing safener for foxtail millet against metolachlor injury, and "Cyometrinil" or "CGA-43089" ((Z)-cyanomethoxyimino(phenyl)acetonitrile) (S11-3), a known seed dressing safener for foxtail millet / sorghum against metolachlor injury.

[0127] S12) Active ingredients from the class of isothiochromanones (S12), for example methyl [(3-oxo-1H-2-benzothiopyran-4(3H)-ylidene)methoxy]acetate (CAS reg.no. 205121-04-6) (S12-1) and related compounds (from WO-A-1998 / 13361).

[0128] S13) One or more compounds (S13) selected from the group consisting of: "naphthalic anhydride" (1,8-naphthalenedicarboxylic anhydride) (S13-1), known as a seed dressing safener for corn against injury by thiocarbamate herbicides; "fenclorim" (4,6-dichloro-2-phenylpyrimidine) (S13-2), known as a seed dressing safener for pretilachlor in sown rice; "flurazole" (2-chloro-4-trifluoromethyl-1,3-thiazole-5-benzyl carboxylate) (S13-3), known as a seed dressing safener for foxtail millet against injury by alachlor and metolachlor; "CL 304415" (CAS reg. no. 31541-57-8) (4-carboxy-3,4-dihydro-2H-1-benzopyran-4-acetic acid) (S13-4) [American Cyanamid], which is a known safener for corn against injury by imidazolinones, "MG 191" (CAS reg. no. 96420-72-3) (2-dichloromethyl-2-methyl-1,3-dioxolane) (S13-5) [from Nitrokemia], which is a known safener for corn, "MG 838" (CAS reg. no. 133993-74-5) (2-propenyl 1-oxa-4-azaspiro[4.5]decane-4-carbodithioate) (S13-6) [from Nitrokemia], "disulfoton" (O,O-diethyl S-2-ethylthioethyl phosphorodithioate) (S13-7), "dietholate" (O,O-diethyl O-phenylphosphorothioate) (S13-8), "mephenate" (4-chlorophenyl methylcarbamate) (S13-9).

[0129] S14) Active ingredients that have a herbicidal effect against harmful plants as well as a phytotoxicity reducing effect against crop plants such as rice, e.g. "Dimepyrate" or "MY 93" (S-1-methyl-1-phenylethylpiperidine-1-carbothioate), known as a safener for rice against damage caused by the herbicide molinate; "Dymron" or "SK 23" (1-(1-methyl-1-phenylethyl)-3-p-tolylurea), known as a safener for rice against damage caused by the herbicide imazosulfuron; "Cumylron" = "JC 940" (3-(2-chlorophenylmethyl)-1-(1-methyl-1-phenylethyl)urea, (see JP-A-60087254), known as a safener for rice against damage caused by some herbicides; "Methoxyphenone" or "NK "049" (3,3'-dimethyl-4-methoxybenzophenone), which is known as a safener for rice against injury by some herbicides; "CSB" (1-bromo-4-(chloromethylsulfonyl)benzene) from Kumiai (CAS reg. no. 54091-06-4), which is known as a safener for injury by some herbicides in rice.

[0130] S15) Compounds of formula (S15) or tautomers thereof (which are described in WO-A-2008 / 131861 and WO-A-2008 / 131860). [ka] [During the ceremony, R H 1 is a (C1-C6)-haloalkyl radical, and R H 2 is hydrogen or a halogen, and R H 3 , R H 4 are independently hydrogen, (C1-C 16 )Alkyl, (C2-C 16 ) alkenyl or (C2-C 16)alkynyl, in which the last three radicals are each unsubstituted or substituted with one or more radicals selected from the group of halogen, hydroxy, cyano, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)alkylthio, (C1-C4)alkylamino, di[(C1-C4)alkyl]amino, [(C1-C4)alkoxy]carbonyl, [(C1-C4)haloalkoxy]carbonyl, unsubstituted or substituted (C3-C6)-cycloalkyl, unsubstituted or substituted phenyl, and unsubstituted or substituted heterocyclyl, or (C3-C6)cycloalkyl, (C4-C6)cycloalkenyl, (C3-C6)cycloalkyl, in which the ring is fused on one side of the ring to a 4- to 6-membered saturated or unsaturated carbocyclic ring. or (C4-C6)cycloalkenyl, which is fused at one side of the ring to a 4-6 membered saturated or unsaturated carbocyclic ring, in which the last four radicals are each unsubstituted or substituted with one or more radicals selected from the group: halogen, hydroxyl, cyano, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)alkylthio, (C1-C4)alkylamino, di[(C1-C4)alkyl]amino, [(C1-C4)alkoxy]carbonyl, [(C1-C4)haloalkoxy]carbonyl, unsubstituted or substituted (C3-C6)-cycloalkyl, unsubstituted or substituted phenyl and unsubstituted or substituted heterocyclyl, or R H 3 is (C1-C4)-alkoxy, (C2-C4)-alkenyloxy, (C2-C6)-alkynyloxy or (C2-C4)-haloalkoxy, and R H 4 is hydrogen or (C1-C4)-alkyl, or RH 3 and R H 4 is, together with the directly attached nitrogen atom, a 4-8 membered heterocyclic ring, which in addition to the nitrogen atom can also contain further ring heteroatoms, preferably up to two further ring heteroatoms selected from the group consisting of N, O and S, and which is unsubstituted or substituted with one or more radicals selected from the group consisting of halogen, cyano, nitro, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio.

[0131] S16) Active ingredients used primarily as herbicides but also having a safening effect on crop plants, such as (2,4-dichlorophenoxy)acetic acid (2,4-D), (4-chlorophenoxy)acetic acid, (R,S)-2-(4-chloro-o-tolyloxy)propionic acid (mecoprop), 4-(2,4-dichlorophenoxy)butyric acid (2,4-DB), (4-chloro-o-tolyloxy)acetic acid (MCPA), 4-(4-chloro-o-tolyloxy)butyric acid, 4-(4-chlorophenoxy)butyric acid, 3,6-dichloro-2-methoxybenzoic acid (dicamba), 3,6-dichloro-2-methoxybenzoic acid 1-(ethoxycarbonyl)ethyl (lactidichlor-ethyl).

[0132] Particularly preferred safeners are mefenpyr-diethyl, cyprosulfamide, isoxadifen-ethyl, cloquintocet-mexyl, dichlormid and metcamifen.

[0133] Wettable powders are preparations which can be homogeneously dispersed in water and which, in addition to the active ingredient, also contain, apart from diluents or inert substances, further surfactants of ionic and / or non-ionic type (wetting agents, dispersants), such as, for example, polyethoxylated alkylphenols, polyethoxylated fatty alcohols, polyethoxylated fatty amines, fatty alcohol polyglycol ether sulfates, alkanesulfonates, alkylbenzenesulfonates, sodium lignosulfonate, sodium 2,2'-dinaphthylmethane-6,6'-disulfonate, sodium dibutylnaphthalenesulfonate or sodium oleoyl methyl taurate. To produce wettable powders, the active herbicidal ingredient is comminuted in customary equipment, such as, for example, hammer mills, blower mills and air jet mills, and simultaneously or subsequently mixed with the formulation auxiliaries.

[0134] Emulsifiable concentrates are prepared by dissolving the active ingredient in an organic solvent, such as butanol, cyclohexanone, dimethylformamide, xylene or aromatic substances or hydrocarbons with relatively high boiling points or mixtures of such organic solvents, and adding one or more surfactants (emulsifiers), ionic and / or non-ionic. Examples of emulsifiers which may be used are: alkylarylsulfonates, such as calcium dodecylbenzenesulfonate, or non-ionic emulsifiers, such as fatty acid polyglycol esters, alkylaryl polyglycol ethers, fatty alcohol polyglycol ethers, propylene oxide / ethylene oxide condensates, alkyl polyethers, sorbitan esters, such as sorbitan fatty acid esters, or polyoxyethylene sorbitan esters, such as polyoxyethylene sorbitan fatty acid esters.

[0135] Dusting products are obtained by grinding the active ingredient with finely divided solids, such as talc, natural clays such as kaolin, bentonite and pyrophyllite, or diatomaceous earth.

[0136] Suspension concentrates can be aqueous or oil-based. They can be prepared, for example, by wet-grinding using commercial bead mills and, optionally, with the addition of surfactants, for example those already mentioned above for the other formulation types.

[0137] Emulsions, e.g. aqueous emulsions (EW), can be prepared, for example, using aqueous organic solvents and, optionally, surfactants, e.g. as already mentioned above for the other formulation types, using stirrers, colloid mills and / or static mixers.

[0138] Granules can be prepared by spraying the active ingredient onto the surface of an adsorbent granular inert material, or by applying a concentrate of the active ingredient onto the surface of a carrier (e.g. sand, kaolinite or granular inert material) with an adhesive (e.g. polyvinyl alcohol, sodium polyacrylate or mineral oil). It is also possible to granulate suitable active ingredients (as a mixture with fertilizer, if necessary) in a conventional manner for preparing fertilizer granules.

[0139] Water-dispersible granules are generally prepared by conventional methods such as spray drying, fluid bed granulation, pan granulation, mixing with high speed mixers, and extrusion without solid inert materials.

[0140] For the preparation of bread, fluid bed, extrusion and spray granules, see, for example, the methods described in "Spray-Drying Handbook", 3rd Edition, 1979, G. Goodwin Ltd., London; JE Browning, "Agglomeration", Chemical and Engineering 1967, p. 147 ff.; and "Perry's Chemical Engineer's Handbook", 5th Edition, McGraw-Hill, New York 1973, pp. 8-57.

[0141] For further details regarding the formulation of crop protection agents, see, for example, G.C. Klingman, "Weed Control as a Science", John Wiley and Sons, Inc., New York, 1961, pp. 81-96 and J.D. Freyer, S.A. Evans, "Weed Control Handbook", 5th ed., Blackwell Scientific Publications, Oxford, 1968, pp. 101-103.

[0142] Agrochemical preparations generally contain 0.1% to 99% by weight, in particular 0.1% to 95% by weight, of the compound of the invention. In wettable powders (dusts), the concentration of the active ingredient is, for example, about 10% to 90% by weight, the remainder up to 100% by weight being made up of customary formulation ingredients. In emulsifiable concentrates, the concentration of the active ingredient can be about 1% to 90% by weight, preferably 5% to 80% by weight. Formulations in the form of dusts contain 1% to 30% by weight of active ingredient, preferably usually 5% to 20% by weight, and sprayable solutions contain about 0.05% to 80% by weight, preferably 2% to 50% by weight, of active ingredient. In the case of wettable powders, the content of the active ingredient depends in part on whether the active compound is present in liquid or solid form, and in part on what granulation aids, fillers, etc. are used. In the water dispersible granule, the content of the active ingredient is, for example, 1 to 95% by weight, or preferably 10 to 80% by weight.

[0143] Furthermore, the above-mentioned formulations of the active compounds optionally contain the respective customary adhesives, wetting agents, dispersants, emulsifiers, penetrants, preservatives, antifreeze agents and solvents, extenders, carriers and dyes, antifoaming agents, evaporation inhibitors, and agents for influencing pH and viscosity.

[0144] On the basis of these formulations, it is also possible to prepare combinations with other pesticidal active substances (e.g. insecticides, acaricides, herbicides, fungicides) and also with safeners, fertilizers and / or growth regulators, for example in the form of finished formulations or as tank mixes.

[0145] For application, the commercial formulations are, where appropriate, diluted in the customary manner, for example with water in the case of wettable powders (dusts), emulsifiable concentrates, dispersions and water-dispersible granules. Preparations in dust form, granules for soil application or for broadcasting and sprayable solutions are usually not further diluted with other inert substances before application.

[0146] The required application rate of the compounds of formula (I) and their salts depends, inter alia, on the external conditions such as temperature, humidity, etc. and on the type of herbicide used. It can vary within a wide range. For example, from 0.001 to 10.0 kg / ha or more of active substance. However, it is preferably between 0.005 and 5 kg / ha, more preferably in the range of 0.01 to 1.5 kg / ha, particularly preferably in the range of 0.05 to 1 kg / ha. This applies both to pre-emergence and post-emergence application.

[0147] The carrier is a natural or synthetic organic or inorganic substance that is mixed or combined with the active ingredient to improve applicability, especially for application to plants or plant parts or seeds. Such carriers can be solid or liquid, but generally should be inert and suitable for use in agriculture.

[0148] Useful solid or liquid carriers include, for example, ammonium salts and natural rock flours, such as kaolin, clay, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, synthetic rock flours, such as micronized silica, alumina and natural or synthetic silicates, resins, waxes, solid fertilizers, water, alcohol, in particular butanol, organic solvents, mineral and vegetable oils and their derivatives. Mixtures of such carriers may also be used. Useful solid carriers for granules include, for example, crushed and fractionated natural rocks, such as calcite, marble, pumice, sepiolite, dolomite, synthetic granules consisting of inorganic and organic meal, and also granules consisting of organic materials, such as sawdust, coconut shells, corn cobs and tobacco stems.

[0149] Suitable liquefied gas extenders or carriers are liquids that are gases at standard temperature and atmospheric pressure, such as aerosol propellants, for example, halogenated hydrocarbons, or butane, propane, nitrogen, and carbon dioxide.

[0150] In the above formulations, tackifiers can be used, such as carboxymethylcellulose, natural and synthetic polymers in the form of powders or granules or latexes, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, or natural phospholipids, such as cephalin and lecithin, as well as synthetic phospholipids, etc. Further additives can be mineral and vegetable oils.

[0151] When the extender used is water, for example, organic solvents can also be used as auxiliary solvents.Useful liquid solvents are essentially the following: aromatic compounds, such as xylene, toluene or alkylnaphthalenes, chlorinated aromatic compounds and chlorinated aliphatic hydrocarbons, such as chlorobenzenes, chloroethylenes or dichloromethane, aliphatic hydrocarbons, such as cyclohexane or paraffins, such as mineral oil fractions, mineral oils and vegetable oils, alcohols, such as butanol or glycols and their ethers and esters, ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents, such as dimethylformamide and dimethylsulfoxide, and also water.

[0152] The compositions of the present invention may additionally contain further ingredients, such as, for example, surfactants. Useful surfactants are emulsifiers and / or foam formers, dispersing agents or wetting agents having ionic or non-ionic properties, or mixtures of such surfactants. Examples of these are salts of polyacrylic acid, salts of lignosulfonic acid, salts of phenolsulfonic acid or naphthalenesulfonic acid, polycondensates of ethylene oxide and fatty alcohols or fatty acids or fatty amines, substituted phenols (preferably alkylphenols or arylphenols), salts of sulfosuccinic acid esters, taurine derivatives (preferably alkyl taurates), phosphoric esters of polyethoxylated alcohols or phosphate esters of polyethoxylated phenols, fatty acid esters of polyols, and derivatives of compounds containing sulfate, sulfonate and phosphate anions, such as alkylaryl polyglycol ethers, alkylsulfonates, alkylsulfates, arylsulfonates, protein hydrolysates, lignosulfite waste liquors and methylcellulose. If one of the active ingredients and / or one of the inert carriers is water-insoluble and application is carried out with water, it is necessary to have a surfactant present. The proportion of surfactant is between 5% and 40% by weight of the composition according to the invention. Colorants such as inorganic pigments, such as iron oxide, titanium oxide, and Prussian Blue, organic dyes, such as alizarin dyes, azo dyes, and metal phthalocyanine dyes, and micronutrients, such as iron salts, manganese salts, boron salts, copper salts, cobalt salts, molybdenum salts, and zinc salts, can be used.

[0153] If appropriate, additional further ingredients may also be present, such as protective colloids, binders, adhesives, thickeners, thixotropic substances, penetrating agents, stabilizers, sequestering agents, complexing agents, etc. In general, the active ingredient can be combined with any solid or liquid additive commonly used for formulation purposes. In general, the compositions and formulations according to the invention contain 0.05% to 99% by weight, 0.01% to 98% by weight, preferably 0.1% to 95% by weight, and more preferably 0.5 to 90% by weight, and most preferably 10 to 70% by weight, of the active ingredient. The active ingredients or compositions according to the invention can be used as they are or in the form of their formulations or in the use forms prepared therefrom, depending on their individual physical and / or chemical properties, such as aerosols, capsule suspensions, cold-fogging concentrates, warm-fogging concentrates, encapsulated granules, fine granules, seed treatment flowables, ready-to-use solutions, dustable powders, emulsifiable concentrates, aqueous emulsions, oil emulsions, large granules, fine granules, oil-dispersible powders, oil-mixed flowables, oil-mixed solutions, foams, pastes, pesticide-coated seeds, suspensions, suspo-emulsions, soluble concentrates, suspensions, sprayable powders, soluble powders, soluble powders, dusts and granules, water-soluble granules or tablets, water-soluble dusts for seed treatment, wettable powders (powders), natural and synthetic substances impregnated with the active ingredient, also microencapsulated in polymeric substances and in coating substances for seeds, and also ULV cold-fogging formulations and ULV warm-fogging formulations.

[0154] The formulations can be prepared in a manner known per se, for example by mixing the active ingredient with at least one customary extender, solvent or diluent, emulsifier, dispersant and / or binder or fixative, wetting agent, water repellent, optionally drying agents and UV stabilizers, optionally dyes and pigments, defoamers, preservatives, secondary thickeners, tackifiers, gibberellins and further processing aids.

[0155] The compositions of the present invention include formulations which are already ready for use and can be applied to plants or seeds using suitable equipment, as well as commercially available concentrates which must be diluted with water before use.

[0156] The active ingredient according to the invention may be present on its own or in its (commercially standard) formulation or in a use form prepared from such a formulation, as a mixture with other (known) active ingredients, such as insecticides, attractants, sterilants, bactericides, acaricides, nematicides, fungicides, growth regulators, herbicides, fertilizers, safeners or semiochemicals.

[0157] The treatment of plants and plant parts with the active ingredients or compositions according to the invention is carried out directly by customary treatment methods, such as immersion, spraying, spraying, irrigation, vaporization, dusting, fume, broadcasting, foaming, painting, spreading-on, watering (drenching), drip irrigation, etc., or by applying the active ingredients or compositions to the surroundings, habitat or storage space of the plants and plant parts, and in the case of the propagation organs, in particular the seeds, also by dry seed treatment, wet seed treatment, as a solution for seed treatment, slurry seed treatment, incrustation, coating with one or more layers of coating. Furthermore, the active ingredients can also be applied by ultra-low volume methods or the active ingredient preparations or the active ingredients themselves can be injected into the soil.

[0158] As also described below, the treatment of transgenic seeds with the active ingredient or composition of the present invention is particularly important. This concerns the seeds of plants that contain at least one heterologous gene that allows the expression of a polypeptide or protein with insecticidal properties. The heterologous gene in transgenic seeds can be derived from, for example, a microorganism of Bacillus sp., Rhizobium sp., Pseudomonas sp., Serratia sp., Trichoderma sp., Clavibacter sp., Glomus sp. or Gliocladium sp. This heterologous gene is preferably derived from Bacillus sp., and in that case, its gene product is effective against European corn borer and / or Western corn rootworm. The heterologous gene is more preferably derived from Bacillus thuringiensis.

[0159] In the context of the present invention, the composition of the present invention is applied to seeds alone or in a suitable formulation.Preferably, the seeds are treated in a sufficiently stable state so that no damage occurs during the treatment.Generally, the seeds can be treated at any time between harvesting and sowing.Customarily, seeds that are separated from the plant and do not have cobs, husks, petioles, husks, hairs or flesh are used.For example, seeds that have been harvested, cleaned and dried to a moisture content of less than 15% by weight can be used.Alternatively, seeds that have been treated, for example with water after drying and then dried again can be used.

[0160] In general, when treating seeds, care must be taken to select the amount of the composition of the invention and / or the amount of further additives applied to the seeds so that the germination of the seeds is not impaired and the plants resulting from the seeds are not damaged.This must be especially taken in the case of active ingredients that may show phytotoxic effects at certain application rates.

[0161] The composition of the present invention can be applied directly, i.e. without containing other components and without dilution.Generally, it is preferred to apply the composition to seeds in the form of a suitable formulation.Suitable formulations and methods for treating seeds are known to those skilled in the art and are described, for example, in the following documents: US4,272,417A, US4,245,432A, US4,808,430, US5,876,739, US2003 / 0176428A1, WO2002 / 080675A1, WO2002 / 028186A2.

[0162] The active ingredients of the present invention can be converted into conventional seed dressing formulations, such as solutions, emulsions, suspensions, dusts, foams, slurries or other coating compositions for seeds, and further into ULV formulations.

[0163] These formulations are prepared in known manner by mixing the active ingredient with customary additives, such as customary extenders and solvents or diluents, colorants, wetting agents, dispersants, emulsifiers, antifoaming agents, preservatives, secondary thickeners, adhesives, gibberellins, and the like, and further mixing with water.

[0164] The coloring agents that can be present in the seed dressing formulations that can be used according to the present invention are all coloring agents that are customary for such purposes. Both pigments that are poorly soluble in water and dyes that are soluble in water can be used. Examples thereof include the coloring agents known under the names Rhodamin B, CI Pigment Red 112 and CI Solvent Red 1.

[0165] Useful wetting agents that can be present in the seed dressing formulations that can be used according to the invention are all substances that promote wetting that are customary for the formulation of agrochemical active ingredients. Preferably, alkylnaphthalenesulfonates, such as diisopropylnaphthalenesulfonate or diisobutylnaphthalenesulfonate, can be used.

[0166] Suitable dispersants and / or emulsifiers that can be present in the seed dressing formulations that can be used according to the invention are all nonionic, anionic and cationic dispersants that are customary for the formulation of agrochemical active ingredients. Preferably, nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants can be used. Suitable nonionic dispersants include, in particular, ethylene oxide / propylene oxide block copolymers, alkylphenol polyglycol ethers and tristryrylphenol polyglycol ethers, as well as their phosphorylated or sulfated derivatives. Suitable anionic dispersants are, in particular, lignosulfonates, polyacrylates and arylsulfonate-formaldehyde condensates.

[0167] Antifoaming agents that may be present in the seed dressing formulations that can be used according to the invention are all foam-inhibiting substances customary for the formulation of agrochemical active ingredients. Preferably, silicone antifoaming agents and magnesium stearate can be used.

[0168] Preservatives which may be present in the seed dressing formulations which may be used according to the invention are all substances which may be used for this purpose in agrochemical compositions, examples of which include dichlorophene and benzyl alcohol hemiformal.

[0169] The second thickeners that can be present in the seed dressing formulations that can be used according to the invention are all substances that can be used for this purpose in agrochemical compositions.Preferred examples include cellulose derivatives, acrylic acid derivatives, xanthan, modified clays and finely divided silica.

[0170] Useful adhesives that can be present in the seed dressing formulations that can be used according to the present invention are all conventional binders that can be used in seed dressing products. Preferred examples include polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and tylose.

[0171] The seed dressing formulations which can be used according to the invention can be used directly or after prior dilution with water to treat a wide variety of different seeds, including those of transgenic plants, where additive synergistic effects may occur in the interaction with the substances formed by expression.

[0172] For the treatment of seeds with the seed dressing formulation that can be used according to the present invention or the preparation prepared from the seed dressing formulation by adding water, the useful equipment is all the mixing equipment that can be used for seed dressing.Specifically, the seed dressing procedure is to put the seeds into the mixer, add the desired specific amount of seed dressing formulation, either as is or after diluting with water in advance, and mix them until the formulation is distributed homogeneously on the surface of the seed.If appropriate, a drying step is performed subsequently.

[0173] The active ingredients of the present invention are suitable for protecting plants and plant organs, for increasing yield, and for improving the quality of harvested crops, when they show good compatibility with plants, have favorable toxicity to homeothermic animals, and have good compatibility with the environment.They can preferably be used as crop protection agents.They are active against normal sensitive and resistant species, and are active against all or specific developmental stages.

[0174] Plants which can be treated according to the invention include the following main crop plants: corn, soybean, cotton, Brassica oil seeds, such as Brassica napus (e.g. canola), Brassica rapa, B. juncea (e.g. (field) mustard) and Brassica carinata, rice, wheat, sugar beet, sugar cane, oats, rye, barley, millet, triticale, flax, grapes, as well as various fruits and vegetables belonging to different botanical taxa, such as Rosaceae sp. (e.g. pome fruits, such as apple and pear, as well as stone fruits, such as apricot, cherry, almond and peach, and berries, such as strawberry), Ribesioidae sp. sp.), Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (e.g. banana trees and plantations), Rubiaceae sp. (e.g. coffee), Theaceae sp., Sterculiceae sp., Rutaceae sp. (e.g. lemons, oranges and grapefruit); Solanaceae sp. (e.g., tomato, potato, pepper, eggplant), Liliaceae sp., Compositae sp. (e.g., lettuce, artichoke and chicory (which includes root chicory, endive or common chicory), Umbelliferae sp.) (e.g., carrot, parsley, celery and celeriac), Cucurbitaceae sp. (e.g., cucumber (which includes gherkins), pumpkin, watermelon, gourd and melon), Alliaceae sp. (e.g., leek and onion), Cruciferae sp. (e.g., white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, Chinese cabbage, kohlrabi, radish, horseradish, cress and Chinese cabbage), Leguminosae sp. (e.g., peanut, pea and kidney bean (e.g., common bean and fava bean)), Chenopodiaceae sp. sp. (e.g. Swiss chard, fodder beet, spinach, beetroot), Malvaceae (e.g. okra), Asparagaceae (e.g. asparagus); useful and ornamental plants in gardens and forests; and, in each case, genetically modified versions of these plants.

[0175] As stated above, all plants and their parts can be treated according to the invention. In a preferred embodiment, wild plant species and plant cultivars or plant species and cultivars obtained by conventional biological breeding methods such as crossing or protoplast fusion, as well as their parts, are treated. In a further preferred embodiment, transgenic plants and plant cultivars obtained by genetic engineering methods, where appropriate in combination with conventional methods (genetically modified organisms) and their parts are treated. The terms "parts" or "parts of plants" or "plant parts" have been explained above. Particularly preferred according to the invention is the treatment of plants of the respective plant cultivars that are commercially conventional or in use. Plant cultivars are understood to mean plants with new properties ("traits") that have been cultivated by conventional breeding or by mutagenesis or recombinant DNA techniques. They can be cultivars, varieties, biotypes or genotypes.

[0176] The treatment method of the present invention can also be used to treat genetically modified organisms (GMOs), such as plants or seeds. A genetically modified plant (or transgenic plant) is a plant in which a heterologous gene is stably integrated into the genome. The term "heterologous gene" essentially means a gene provided or constructed outside the plant, which when introduced into the nuclear, chloroplast or mitochondrial genome, confers new or improved agronomic properties or other traits to the transformed plant by expressing a protein or polypeptide of interest or by downregulating or switching off one or more other genes present in the plant (e.g., using antisense, cosuppression or RNAi technology [RNA interference]). A heterologous gene present in a genome is also referred to as a transgene. A transgene, defined by its specific presence in a plant genome, is referred to as a transformation or transgenesis event.

[0177] Depending on the plant species or plant varieties, their growing location and growing conditions (soil, climate, growing season, nutrients (diet)), the treatment of the present invention may also produce effects that are more than additive ("synergistic effects"). For example, the following effects beyond the actual expected effects are possible: reduction in the application rate and / or broadening of the activity spectrum and / or increasing the efficacy of the active ingredients and compositions that can be used according to the present invention, improved plant growth, improved resistance to high or low temperatures, improved resistance to drought or salt in water or soil, improved flowering ability, improved ease of harvesting, accelerated maturation, increased yield, increased fruit size, increased plant height, improved leaf greenness, earlier flowering, improved quality and / or increased nutritional value of harvested products, increased sugar content in fruits, improved storage stability and / or improved processability of harvested products.

[0178] Plants and plant cultivars which are preferably treated according to the invention include all plants which have genetic material (whether obtained by breeding and / or by biotechnological means) which confer particularly advantageous and useful traits on the plant.

[0179] Examples of nematode-resistant plants are described, for example, in the following U.S. patent applications: 11 / 765,491, 11 / 765,494, 10 / 926,819, 10 / 782,020, 12 / 032,479, 10 / 783,417, 10 / 782,096, 11 / 657,964, 12 / 192,904, 1 1 / 396,808, 12 / 166,253, 12 / 166,239, 12 / 166,124, 12 / 166,209, 11 / 762,886, 12 / 364,335, 11 / 763,947, 12 / 252,453, 12 / 209,354, 12 / 491,396 and 12 / 497,221.

[0180] Plants that may be treated according to the invention are hybrid plants that already exhibit the properties of hybrid vigor or hybrid effect, which generally result in increased yield, improved vigor, improved health and improved resistance to biotic and abiotic stress factors. Such plants are typically produced by crossing a male-sterile inbred parent line (female cross breeding parent) with another male-fertile inbred parent line (male cross breeding parent). Hybrid seeds are typically harvested from the male-sterile plants and sold to growers. Male-sterile plants can sometimes be produced (e.g. in corn) by detasseling (i.e. by mechanically removing the male reproductive organs or male flowers). More typically, however, male sterility is the result of genetic determinants within the plant genome. In that case, and especially when seeds are the desired product to be harvested from a hybrid plant, it is typically beneficial to ensure that male fertility is fully restored in the hybrid plant that contains the genetic determinant responsible for male sterility. This can be achieved by ensuring that the male cross breeding parent has a suitable fertility restorer gene that can restore male fertility in the hybrid plant that contains the genetic determinant responsible for male sterility. The genetic determinant for male sterility can be present in the cytoplasm. Examples of cytoplasmic male sterility (CMS) have been described, for example, for Brassica species. However, the genetic determinant for male sterility can also be present in the nuclear genome. Male sterile plants can also be obtained by plant biotechnology methods such as genetic engineering. A particularly useful method for obtaining male-sterile plants is described in WO 89 / 10396, in which, for example, a ribonuclease such as barnase is selectively expressed in the tapetum cells within the stamens. Fertility can then be restored by expressing a ribonuclease inhibitor such as barstar in the tapetum cells.

[0181] Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that can be treated according to the invention are herbicide-tolerant plants, i.e. plants that have been made tolerant to one or more given herbicides. Such plants can be obtained by genetic transformation or by selecting plants that contain a mutation that confers resistance to the herbicide in question.

[0182] Herbicide-resistant plants are, for example, glyphosate-resistant plants, i.e. plants that have been made tolerant to the herbicide glyphosate or its salts. Plants can be made tolerant to glyphosate by various methods. Thus, for example, glyphosate-resistant plants can be obtained by transforming plants with a gene encoding the enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS). Examples of such EPSPS genes are the AroA gene (mutation CT7) of the bacterium Salmonella typhimurium (Comai et al., 1983, Science 221, 370-371), the CP4 gene of the bacterium Agrobacterium sp. (Barry et al., 1992, Curr. Topics Plant Physiol. 7, 139-145), the gene encoding EPSPS of Petunia (Shah et al., 1986, Science 233, 478-481), the gene encoding EPSPS of tomato (Gasser et al., 1988, J. Biol. Chem. 263, 4280-4289) or the gene encoding EPSPS of Eleusine (WO 01 / 66704). It may also be a mutant EPSPS. Glyphosate-tolerant plants can also be obtained by expressing a gene encoding a glyphosate oxidoreductase enzyme. Glyphosate-tolerant plants can also be obtained by expressing a gene encoding a glyphosate acetyltransferase enzyme. Glyphosate-tolerant plants can also be obtained by selecting plants containing naturally occurring mutations of the above genes. Plants expressing an EPSPS gene that confers glyphosate tolerance have been described. Plants expressing another gene (e.g., a decarboxylase gene) that confers glyphosate tolerance have been described.

[0183] Other herbicide-resistant plants are, for example, plants that have been made tolerant to herbicides that inhibit the enzyme glutamine synthase (e.g., bialaphos, phosphinothricin or glufosinate). Such plants can be obtained by expressing an enzyme that detoxifies the herbicide in question or by expressing a mutant glutamine synthase enzyme that is resistant to inhibition. One example of such an effective detoxifying enzyme is an enzyme that codes for phosphinothricin acetyltransferase (e.g., the bar or pat proteins from Streptomyces species). Plants that express exogenous phosphinothricin acetyltransferase have been described.

[0184] Further herbicide-resistant plants are also plants that are made tolerant to herbicides that inhibit the enzyme hydroxyphenylpyruvate dioxygenase (HPPD). Hydroxyphenylpyruvate dioxygenases are enzymes that catalyze the reaction in which para-hydroxyphenylpyruvate (HPP) is converted to homogentisate. Plants that are resistant to HPPD inhibitors can be transformed with a gene that codes for a naturally occurring resistant HPPD enzyme, or with a gene that codes for a mutant HPPD enzyme or a chimeric HPPD enzyme, as described in WO96 / 38567, WO99 / 24585, WO99 / 24586, WO2009 / 144079, WO2002 / 046387 or US6,768,044. Resistance to HPPD inhibitors can also be obtained by transforming plants with a gene that codes for a specific enzyme that can form homogentisate despite the inhibition of the native HPPD enzyme by HPPD inhibitors. Such plants are described in WO99 / 34008 and WO02 / 36787. The resistance of plants to HPPD inhibitors can also be improved by transforming plants with a gene encoding prephenate dehydrogenase enzyme in addition to the gene encoding HPPD resistance enzyme, as described in WO2004 / 024928. Furthermore, plants can be made more resistant to HPPD inhibitors by inserting into their genome a gene encoding an enzyme (e.g., CYP450 enzyme) that metabolizes or degrades HPPD inhibitors (see WO2007 / 103567 and WO2008 / 150473).

[0185] Other herbicide-resistant plants are plants that are made tolerant to acetolactate synthase (ALS) inhibitors. Known ALS inhibitors include, for example, sulfonylurea herbicides, imidazolinone herbicides, triazolopyrimidine herbicides, pyrimidinyloxy(thio)benzoate herbicides, and / or sulfonylaminocarbonyltriazolinone herbicides. Various mutations in ALS enzymes (also known as "acetohydroxyacid synthase (AHAS)") are known to confer resistance to various herbicides and groups of herbicides, as described, for example, in Tranel and Wright (Weed Science 2002, 50:700-712). The creation of sulfonylurea-resistant and imidazolinone-resistant plants has been described. Further sulfonylurea-resistant and imidazolinone-resistant plants have also been described.

[0186] Further plants showing resistance to imidazolinones and / or sulfonylureas can be obtained by induced mutagenesis, by selection in cell culture in the presence of the herbicide or by mutation breeding (see, for example, US 5,084,082 for soybean, WO 97 / 41218 for rice, US 5,773,702 and WO 99 / 057965 for sugar beet, US 5,198,599 for lettuce or WO 01 / 065922 for sunflower).

[0187] Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention are resistant to abiotic stress factors. Such plants can be obtained by genetic transformation or by selecting plants containing mutations that confer such stress resistance. Particularly useful stress-tolerant plants include: a. a plant comprising a transgene capable of reducing the expression and / or activity of the poly(ADP-ribose) polymerase (PARP) gene in a plant cell or in the plant body; b. A plant comprising a stress tolerance enhancing transgene capable of reducing the expression and / or activity of the PARG encoding gene in the plant or plant cell; c. Plants containing a stress-tolerance enhancing transgene encoding a plant-functional enzyme of the nicotinamide adenine dinucleotide salvage biosynthetic pathway, including nicotinamidase, nicotinic acid phosphoribosyltransferase, nicotinic acid mononucleotide adenyltransferase, nicotinamide adenine dinucleotide synthetase, or nicotinamide phosphoribosyltransferase.

[0188] Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention exhibit modified quantity, quality and / or storage stability of the harvested product and / or modified characteristics of certain components of the harvested product, for example: 1) transgenic plants which synthesize modified starches whose physicochemical properties, in particular the amylose content or amylose / amylopectin ratio, the degree of branching, the average chain length, the side chain distribution, the viscous behavior, the gelling strength, the starch granule size and / or the starch granule morphology, are altered compared to the starch synthesized in wild-type plant cells or plants, making them more suitable for certain applications; 2) transgenic plants that synthesize non-starch carbohydrate polymers or that synthesize non-starch carbohydrate polymers with modified properties compared to the non-transgenic wild-type plants, examples being plants that produce polyfructose (in particular inulin- and levan-type polyfructose), plants that produce α-1,4-glucans, plants that produce α-1,6-branched α-1,4-glucans and plants that produce alternan; 3) transgenic plants producing hyaluronan; 4) Transgenic or hybrid plants such as onion that have properties such as "high soluble solids content", "low pungency" (LP) and / or "long shelf life" (LS).

[0189] Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that may also be treated according to the invention are plants with modified fiber properties (for example cotton plants). Such plants can be obtained by genetic transformation or by selecting plants containing a mutation that confers such modified fiber properties. Such plants include: a) a plant (e.g., a cotton plant) that contains an altered form of a cellulose synthase gene; b) a plant (e.g., a cotton plant) containing an altered form of a rsw2 or rsw3 homologous nucleic acid, e.g., a cotton plant having increased expression of sucrose phosphate synthase; c) plants with increased expression of sucrose synthase (e.g., cotton plants); d) plants in which the timing of fiber cell-based plasmodesmata gating is altered (e.g., via downregulation of fiber-selective b-1,3-glucanases) (e.g., cotton plants); e) Plants having fibers with altered reactivity (eg, through expression of N-acetylglucosamine transferase genes, including nodC, and expression of chitin synthase genes) (eg, cotton plants).

[0190] Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that may also be treated according to the present invention are plants (e.g. rapeseed plants or related Brassica plants) with modified oil profile characteristics. Such plants can be obtained by genetic transformation or by selecting plants containing mutations that confer such modified oil characteristics. Such plants include: a) Plants that produce oil with a high oleic acid content (e.g. rapeseed plants); b) plants that produce oils with a low linoleic acid content (e.g., rapeseed plants); c) Plants that produce oils with low levels of saturated fatty acids (e.g., rapeseed plants).

[0191] Plants or plant cultivars (obtainable by plant biotechnology methods such as genetic engineering) which may also be treated according to the invention are plants such as potato exhibiting virus resistance (e.g. virus resistance against potato virus Y (SY230 and SY233 events, from Tecnoplant, Argentina)) or disease resistance (e.g. potato late blight (e.g. RB gene)) or potato exhibiting reduced cold-induced sweetness (which has the gene Nt-Inh, gene II-INV) or potato exhibiting a dwarf phenotype (A-20 oxidase gene).

[0192] Plants or plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that may also be treated according to the present invention are plants (e.g., rapeseed plants or related Brassica plants) with modified seed shattering characteristics. Such plants can be obtained by genetic transformation or by selecting plants containing mutations that confer such modified characteristics. Such plants include plants (e.g., rapeseed plants) in which seed shattering is delayed or reduced.

[0193] Particularly useful transgenic plants that may be treated according to the present invention are plants that contain a transformation event or combination of transformation events that are the subject of a grant or continuing application to the Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture (USDA) for non-regulated status in the United States. Information relating thereto is available at any time from APHIS, 4700 River Road Riverdale, MD 20737, USA, for example via the website "http: / / www.aphis.usda.gov / brs / not_reg.html". As of the filing date of this application, applications bearing the following information have been granted or are pending with APHIS:

[0194] Application: Identification number of the application. A technical description of the conversion event is provided in the specific application documents available from APHIS via their website application number. These descriptions are incorporated herein by reference. · Extension of application: A reference to an earlier application in which an extension in scope or duration is being sought. · Institution: The name of the individual submitting the application. Regulated item: the plant species in question. · Transgenic phenotype: The trait conferred to a plant by a transformation event. Transformation Event or Line: The name of the event or events (sometimes referred to as lines) for which a regulatory exemption is being claimed. APHIS Documents: Various documents that are relevant to the application and have been published by APHIS or are available from APHIS upon request.

[0195] Particularly useful transgenic plants that may be treated according to the present invention are plants that contain one or more genes encoding one or more toxins, such as transgenic plants sold under the following trade names: YIELD GARD® (e.g., corn, cotton, soybean), KnockOut® (e.g., corn), BiteGard® (e.g., corn), BT-Xtra® (e.g., corn), StarLink® (e.g., corn), Bollgard® (cotton), Nucotn® (cotton), Nucotn 33B® (cotton), NatureGard® (e.g., corn), Protecta® and NewLeaf® (potato). Examples of herbicide-resistant plants include corn, cotton and soybean varieties available under the trade names Roundup Ready (resistant to glyphosates, e.g., corn, cotton, soybean), Liberty Link (resistant to phosphinothricin, e.g., rapeseed), IMI (resistant to imidazolinones) and SCS (resistant to sulfonylureas, e.g., corn). Herbicide-resistant plants (plants bred in a conventional manner for herbicide resistance) that may be mentioned include varieties sold under the trade name Clearfield (e.g., corn). EXAMPLES

[0196] The following examples illustrate the invention.

[0197] Working Example The present invention will be described in detail by the following examples, which should not be construed as limiting the present invention in any way.

[0198] Synthesis Examples Ethyl {[4-bromo-5-(6-fluoropyridin-3-yl)-1-(pyrazin-2-yl)-1H-pyrazol-3-yl]oxy}(methylsulfanyl)acetate (I-17): To a solution of 0.64 g (1.90 mmol) of 4-bromo-5-(6-fluoropyridin-3-yl)-1-(pyrazin-2-yl)-1H-pyrazol-3-ol in 12 ml of dimethylformamide, 0.37 g (2.67 mmol) of potassium carbonate was added, the mixture was stirred at room temperature for 10 minutes, 0.25 g (1.47 mmol) of ethyl chloro(methylsulfanyl)acetate was added and the mixture was stirred for 3 hours at 80° C. The mixture was filtered, the filtrate was concentrated under reduced pressure, the residue was dissolved in water and repeatedly extracted with dichloromethane, the combined organic phases were dried over sodium sulfate and the solvent was removed under reduced pressure. After purification by column chromatography on silica gel with heptane / ethyl acetate, 0.32 g (48% of theory) of a solid was obtained. For NMR data, see NMR peak listing method below.

[0199] Synthesis of starting compounds a) 4-Bromo-5-(6-fluoropyridin-3-yl)-1-(pyrazin-2-yl)-1H-pyrazol-3-ol: To 1.22 g (2.86 mmol) of 2-[3-(benzyloxy)-4-bromo-5-(6-fluoropyridin-3-yl)-1H-pyrazol-1-yl]pyrazine was added 5.0 ml of trifluoroacetic acid under argon and the mixture was stirred under reflux for 2 h. The excess trifluoroacetic acid was removed under reduced pressure, the residue was dissolved in dichloromethane and the solvent was removed under reduced pressure. 1.29 g (94% of theory) of solid was obtained with m / z=334(50) [M + ], 336(50)[M + ] was the case.

[0200] b) 2-[3-(benzyloxy)-4-bromo-5-(6-fluoropyridin-3-yl)-1H-pyrazol-1-yl]pyrazine: To a solution of 1.05 g (3.02 mmol) of 2-[3-(benzyloxy)-5-(6-fluoropyridin-3-yl)-1H-pyrazol-1-yl]pyrazine in 35 ml of DMF, 0.82 g (4.53 mmol) of N-bromosuccinimide was added and the mixture was stirred at 65° C. for 2 hours. The solvent was removed under reduced pressure, the residue was dissolved in water and repeatedly extracted with dichloromethane, the combined organic phases were dried over sodium sulfate and the solvent was removed under reduced pressure. After purification by column chromatography on silica gel with heptane / ethyl acetate, 1.22 g (90% of theory) of product was obtained with m / z(%)=426(50)[M + ], 428(50)[M + ] was the case.

[0201] c) 2-[3-(benzyloxy)-5-(6-fluoropyridin-3-yl)-1H-pyrazol-1-yl]pyrazine: To a solution of 2.50 g (9.72 mmol) of 5-(6-fluoropyridin-3-yl)-1-(pyrazin-2-yl)-1H-pyrazol-3-ol in 80 ml of dimethylformamide, 2.42 g (17.50 mmol) of potassium carbonate were added, the mixture was stirred at room temperature for 10 min, 1.65 g (9.62 mmol) of (bromomethyl)benzene was added and stirred at 80° C. for 3 h. The mixture was filtered, the filtrate was concentrated under reduced pressure, the residue was dissolved in water and repeatedly extracted with dichloromethane, the combined organic phases were dried over sodium sulfate and the solvent was removed under reduced pressure. After purification by column chromatography on silica gel with heptane / ethyl acetate, 2.11 g (66% of theory) of solid was obtained, m / z (%)=348 [M + ] was the case.

[0202] d) 5-(6-fluoropyridin-3-yl)-1-(pyrazin-2-yl)-1H-pyrazol-3-ol: To a solution of 3.55 g (8.28 mmol) of 3-(6-fluoropyridin-3-yl)-N'-(pyrazin-2-yl)prop-2-inhydrazide in 7 ml of acetonitrile, 0.08 g (0.66 mmol) of copper(I) iodide was added and the mixture was stirred for 2 hours at 80° C. After purification by column chromatography on silica gel with heptane / ethyl acetate, 1.59 g (75% of theory) of product was obtained with m / z=258 [M + ] was the case. 1 H NMR (400 MHz, DMSO-d6, d, ppm): 10.82 (s, 1H), 9.00 (m, 1H), 8.46 (m, 1H), 8.29 (m, 1H), 8.17 (m, 1H), 8.02-7.97 (m, 1H), 7.32-7.28 (m, 1H), 6.18 (s, 1H).

[0203] e) 3-(6-fluoropyridin-3-yl)-N'-(pyrazin-2-yl)prop-2-yne hydrazide: To a solution of 3.00 g (16.35 mmol) of 3-(6-fluoropyridin-3-yl)prop-2-yne acid in 20 ml of tetrahydrofuran, 2.07 g (18.80 mmol) of 2-hydrazinopyrazine and 8.27 g (81.76 mmol) of triethylamine were successively added. 15.61 g (24.53 mmol) of propanephosphonic anhydride (T3P, 50% solution in tetrahydrofuran) were added dropwise and the mixture was stirred at room temperature for 1 hour. The reaction mixture was poured into water and repeatedly extracted with ethyl acetate, the combined organic phases were dried over sodium sulfate and the solvent was removed under reduced pressure to give 3.55 g (51% of theory) of an oily product (HPLC / MS purity = 60%, m / z = 258 [M + ]) was obtained and further transformed without purification.

[0204] f) 3-(6-fluoropyridin-3-yl)prop-2-ynoic acid: Under an argon atmosphere, to 9.20 g (41.26 mmol) of 2-fluoro-5-iodopyridine in 105 ml of dry tetrahydrofuran were successively added: 2.89 g (41.26 mmol) of propiolic acid, 0.58 g (0.83 mmol) of bis(triphenylphosphine)palladium(ll) dichloride, 0.31 g (1.65 mmol) of copper(I) iodide and 14.61 g (144.41 mmol) of diisopropylamine. The mixture was stirred at room temperature for 2 hours, the reaction mixture was added to water, 30 ml of 2N hydrochloric acid was added and repeatedly extracted with ethyl acetate. The combined organic phases were dried over magnesium sulfate and concentrated under reduced pressure. The residue was mixed with diethyl ether, the mixture was stirred in an ultrasonic bath for 10 minutes, filtered and the solvent was removed under reduced pressure. 6.25 g (78% of theory) of product was obtained, m / z=166 [M + ] was the case. 1 H NMR (600 MHz, DMSO-d6, d, ppm): 14.00 (bs, 1H), 8.57 (m, 1H), 8.32-8.28 (m, 1H), 7.35-7.32 (m, 1H).

[0205] Ethyl {[4-bromo-1-(2,5-difluorophenyl)-5-(5-fluoropyridin-3-yl)-1H-pyrazol-3-yl]oxy}(methylsulfanyl)acetate (I-03): To a solution of 0.38 g (1.01 mmol) of 4-bromo-1-(2,5-difluorophenyl)-5-(5-fluoropyridin-3-yl)-1H-pyrazol-3-ol in 8 ml of dimethylformamide, 0.25 g (1.82 mmol) of potassium carbonate was added, the mixture was stirred at room temperature for 10 min, 0.17 g (1.01 mmol) of ethyl chloro(methylsulfanyl)acetate was added and the mixture was stirred at 80° C. for 3 h. The mixture was filtered, the filtrate was concentrated under reduced pressure, the residue was dissolved in water and repeatedly extracted with dichloromethane, the combined organic phases were dried over sodium sulfate and the solvent was removed under reduced pressure. After purification by column chromatography on silica gel with heptane / ethyl acetate, 0.41 g (86% of theory) of an oil was obtained. For NMR data, see further NMR peak listing method below.

[0206] {[4-Bromo-1-(2,5-difluorophenyl)-5-(5-fluoropyridin-3-yl)-1H-pyrazol-3-yl]oxy}(methylsulfanyl)acetic acid (I-06): To 0.26 g (0.50 mmol) of ethyl {[4-bromo-1-(2,5-difluorophenyl)-5-(5-fluoropyridin-3-yl)-1H-pyrazol-3-yl]oxy}(methylsulfanyl)acetate (I-03) in 8 ml of tetrahydrofuran was added a solution of 0.03 g (1.22 mmol) of lithium hydroxide in 1 ml of water and the mixture was stirred at 25° C. for 2 h. The solvent was removed under reduced pressure, the residue was dissolved in water and extracted twice with dichloromethane, the aqueous phase was adjusted to pH=2-3 with 2M hydrochloric acid and extracted twice with dichloromethane. The combined organic phase was dried over sodium sulfate and the solvent was removed under reduced pressure. A colourless solid (0.21 g, 87% of theory) was obtained. 1H NMR (400 MHz, CDCl3, δ, ppm): 8.49 (d, 1H), 8.29 (s, 1H), 7.49-7.46 (m, 1H), 7.20-7.16 (bm, 1H), 7.11-7.05 (m, 1H), 7.02-6.99 (m, 1H), 6.13 (s, 1H), 2.35 (s, 3H).

[0207] NMR data for selected examples Selected examples of compounds of formula (I) 1 HNMR data can be analyzed in two different ways: (a) by conventional NMR evaluation and interpretation, or (b) by the method described below. 1 The data are given in the form of a HNMR peak list.

[0208] a) Conventional NMR interpretation Example I-06: 1 H NMR (400 MHz, CDCl3, δ, ppm): 8.49 (d, 1H), 8.29 (s, 1H), 7.49-7.46 (m, 1H), 7.20-7.16 (bm, 1H), 7.11-7.05 (m, 1H), 7.02-6.99 (m, 1H), 6.13 (s, 1H), 2.35 (s, 3H).

[0209] Example I-10: 1 H NMR (400 MHz, CDCl3, δ, ppm): 8.10 (s, 1H), 7.72-7.76 (t, 1H), 7.38 - 7.42 (t, 1H), 7.34-7.38 (q, 1H), 7.19-7.23 (t, 1H), 7.01-7.06 (t, 1H), 6.92-6.94 (dd, 1H), 6.10 (s. 1H), 3.85 (s, 3H), 2.33ppm (s, 3H).

[0210] Example I-11: 1H NMR (400 MHz, CDCl3, δ, ppm): 8.29 (d, 1H), 7.43 (dd, 1H), 7.33-7.25 (br m, 6H), 6.16 (s, 1H), 4.29 (pseudo q, 2H), 2.33 (s, 3H), 1.30 (t, 3H).

[0211] Example 1-12: 1 H NMR (400 MHz, CDCl3, δ, ppm): 7.30-7.26 (m, 2H), 7.14 (dd, 1H), 7.05 (dd, 1H), 6.92 (dt, 1H), 6.81 (dt, 1H), 6.04 (s, 1H), 4.33-4.27 (m, 2H), 2.32 (s, 3H), 1.31 (t, 3H).

[0212] Example 1-13: 1 H NMR (400 MHz, CDCl3, δ, ppm): 8.23 ​​(d, 1H), 8.13 (d, 1H), 7.84 (dt, 1H), 7.50 (dt, 1H), 7.34 (dt, 1H), 6.95 (dd, 1H), 6.12 (s, 1H), 4.29 (pseudo q, 2H), 2.33 (s, 3H), 1.31 (t, 3H).

[0213] Example 1-14: 1 H NMR (400 MHz, CDCl3, δ, ppm): 8.13 (d, 1H), 7.50 (dt, 1H), 7.40 (m, 1H), 7.30-7.26 (m, 1H), 6.92 (dt, 1H), 6.76 (dt, 1H), 6.12 (s, 1H), 4.30 (pseudo q, 2H), 2.33 (s, 3H), 1.31 (t, 3H).

[0214] Example 1-15: 1H NMR (400 MHz, CDCl3, δ, ppm): 8.28 (d, 1H), 7.45 (dt, 1H), 7.35-7.23 (br m, 5H), 6.14 (s, 1H), 4.29 (m, 2H), 2.32 (s, 3H), 1.30 (t, 3H).

[0215] Example I-27: 1 H NMR (400 MHz, CDCl3, δ, ppm): 8.24 (d, 1H), 8.13 (d, 1H), 7.84 (dt, 1H), 7.51 (dt, 1H), 7.34 (dt, 1H), 6.95 (dd, 1H), 6.15 (s, 1H), 3.84 (s, 3H), 2.33 (s, 3H).

[0216] Example I-29: 1 H NMR (400 MHz, CDCl3, δ, ppm): 8.23 ​​(d, 1H), 8.13 (d, 1H), 7.84 (dt, 1H), 7.50 (dt, 1H), 7.34 (dt, 1H), 6.95 (dd, 1H), 6.12 (s, 1H), 4.29 (pseudo q, 2H), 2.33 (s, 3H), 1.31 (t, 3H).

[0217] Example I-46: 1 H NMR (600 MHz, CDCl3, δ, ppm): 8.06 (d, 1H), 7.71 (td, 1H), 7.37 (m, 2H), 7.20 (t, 1H), 7.02 (t, 1H), 6.92 (dd, 1H), 6.07 (s, 1H), 4.30 (m, 2H), 2.30 (s, 3H), 1.30 (t, 3H)

[0218] Example I-65: 1H NMR (400 MHz, CDCl3, δ, ppm): 8.19 (m, 1H), 8.10 (m, 1H), 7.83 (m, 1H), 7.62 (m, 1H), 7.21 (m, 1H), 6.91 (m, 1H), 6.06 (s, 1H), 4.31-4.26 (m, 2H), 2.31 (s, 3H), 2.21 (s, 3H), 1.33-1.29 (m, 3H).

[0219] b) NMR peak list method Selected Examples 1 HNMR data, 1 The information is written in the form of a HNMR peak list. For each signal peak, the δ value (ppm) is listed first, followed by the signal intensity (parentheses). The δ value-signal intensity number pairs for different signal peaks are listed, separated from each other by semicolons.

[0220] Thus, an example peak list takes the following form: δ1(Intensity 1);δ2(Intensity 2);...;δ i (strength i );...;δ n (strength n )

[0221] The intensity of the sharp signal correlates with the signal height (cm) in the printed example of the NMR spectrum, giving a true ratio of signal intensities. In the case of broad signals, several peaks or the center of the signal and their relative intensities can be shown in comparison to the most intense signal in the spectrum.

[0222] 1 To calibrate the chemical shifts of H NMR spectra, tetramethylsilane is used and / or, especially if the spectrum is measured in DMSO, the chemical shifts of the solvent are used, so that in the NMR peak list, a peak for tetramethylsilane may be present, but need not be.

[0223] 1 The list of HNMR peaks is given by 1 1 HNMR printout and therefore contains all the peaks that would normally be noted in a conventional NMR interpretation.

[0224] In addition, the conventional 1 As with the HNMR printout, the signals of the solvent, the signals of the stereoisomers of the target compounds as well provided by the present invention and / or the signals of impurity peaks may also be shown.

[0225] In recording compound signals within the delta range of the solvent and / or water, 1 Our list of HNMR peaks shows standard solvent peaks, e.g., DMSO peaks in DMSO-D6, and water peaks, which usually have high intensity on average.

[0226] The peaks of stereoisomers of the target compound and / or the peaks of impurities usually have, on average, lower intensities than the peaks of the target compound (eg, having a purity of greater than 90%).

[0227] Such stereoisomers and / or impurities may be unique to a particular preparation method, and therefore their peaks, in this case, may help to confirm the reproducibility of our preparation method in terms of "by-product fingerprints".

[0228] The expert calculates the peaks of the target compounds by known methods (MestreC, ACD simulation, or using empirically evaluated expected values), and can optionally use additional intensity filters to separate the peaks of the target compounds, if necessary. This separation is more efficient than the conventional 1 This would be similar to the problem of peak picking in H NMR interpretation.

[0229] 1Further details regarding the HNMR peak listings can be found in Research Disclosure Database Number 564025.

[0230] [Table 2]

[0231] TIFF2024542693000054.tif255164

[0232] TIFF2024542693000055.tif250164

[0233] TIFF2024542693000056.tif255164

[0234] TIFF2024542693000057.tif255165

[0235] TIFF2024542693000058.tif250164

[0236] TIFF2024542693000059.tif252164

[0237] TIFF2024542693000060.tif255164

[0238] TIFF2024542693000061.tif255164

[0239] TIFF2024542693000062.tif255164

[0240] TIFF2024542693000063.tif245165

[0241] TIFF2024542693000064.tif250164

[0242] TIFF2024542693000065.tif255164

[0243] TIFF2024542693000066.tif249164

[0244] TIFF2024542693000067.tif255163

[0245] TIFF2024542693000068.tif255164

[0246] TIFF2024542693000069.tif255164

[0247] TIFF2024542693000070.tif176165

[0248] Formulation Examples a) Dusts are obtained by mixing 10 parts by weight of a compound of formula (I) and / or its salt with 90 parts by weight of talc as an inert substance and grinding the mixture in a hammer mill.

[0249] b) A readily water-dispersible wettable powder (powder) is obtained by mixing 25 parts by weight of a compound of formula (I) and / or its salt, 64 parts by weight of kaolin-containing quartz as inert material, 10 parts by weight of potassium lignosulfonate and 1 part by weight of sodium oleoyl methyl taurate as wetting and dispersing agents and grinding the mixture in a pinned disc mill.

[0250] c) A readily water-dispersible dispersion concentrate can be obtained by mixing 20 parts by weight of a compound of formula (I) and / or its salt, 6 parts by weight of an alkylphenol polyglycol ether (Triton X 207), 3 parts by weight of an isotridecanol polyglycol ether (8 EO) and 71 parts by weight of a paraffinic mineral oil (boiling point range, e.g., from about 255 to above 277° C.) and grinding the mixture in a friction ball mill to a fineness of less than 5 microns.

[0251] d) An emulsifiable concentrate is obtained from 15 parts by weight of a compound of formula (I) and / or its salt, 75 parts by weight of cyclohexanone as solvent and 10 parts by weight of ethoxylated nonylphenol as emulsifier.

[0252] e) Water dispersible granules: 75 parts by weight of a compound of formula (I) and / or a salt thereof, 10 parts by weight of calcium lignosulfonate, 5 parts by weight of sodium lauryl sulfate, 3 parts by weight of polyvinyl alcohol, and 7 parts by weight of kaolin The powder is obtained by mixing the above, grinding the mixture in a pinned disc mill, and granulating the powder in a fluidized bed by spraying water as a granulating liquid.

[0253] f) Water dispersible granules can also be mixed in a colloid mill: 25 parts by weight of a compound of formula (I) and / or a salt thereof, 5 parts by weight of sodium 2,2'-dinaphthylmethane-6,6'-disulfonate, 2 parts by weight of sodium oleoyl methyl taurate, 1 part by weight of polyvinyl alcohol, 17 parts by weight of calcium carbonate, and 50 parts by weight of water, It can also be obtained by homogenizing, pre-refining and then grinding in a bead mill and spray-drying the resulting suspension in a spray tower through a one-phase nozzle.

[0254] Biological Examples A. Pre-emergence herbicidal effect and crop plant compatibility The seeds of monocotyledonous and dicotyledonous weed plants and crop plants are placed in plastic or organic planting pots and covered with soil. The compounds of the present invention formulated in the form of wettable powder (WP) or emulsifiable concentrate (EC) are then applied to the surface of the covered soil as aqueous suspension or emulsion, adding 0.5% additive at a water application rate equivalent to 600 l / ha. After treatment, the pots are placed in a greenhouse and kept under good growth conditions for the test plants. After about 3 weeks, the effect of the preparation is visually evaluated as a percentage, compared to untreated control. For example, 100% activity = plant has died, 0% activity = similar to control plant.

[0255] The following Tables A1 and A2 show the effects of selected compounds of general formula (I) according to Table 1 on various harmful plants and application rates equivalent to up to 320 g / ha, obtained by the test procedures specified above. Appendices "a" and "b" give a distinction according to the application rates used on the same harmful plants tested. [Table 3]

[0256] As shown by the results from Tables A1 and A2, the compounds of the present invention have good pre-emergence herbicidal activity against harmful plants such as Amaranthus retroflexus (AMARE) and Polygonum convolvulus (POLCO).

[0257] The compounds of the invention are therefore suitable for controlling undesirable plant growth by the emergence anterior method.

[0258] B. Post-emergence herbicidal activity and crop plant compatibility Seeds of monocotyledonous and dicotyledonous weed and crop plants are placed in sandy loam in plastic or organic planting pots, covered with soil and cultivated in a greenhouse under controlled growth conditions. 2-3 weeks after sowing, the test plants are treated at the one-leaf stage. The compounds of the invention formulated in the form of wettable powders (WP) or emulsifiable concentrates (EC) are then sprayed onto the green parts of the plants as aqueous suspensions or emulsions, with the addition of 0.5% additive in a water application rate equivalent to 600 l / ha. After about 3 weeks of maintaining the test plants in the greenhouse under optimal growth conditions, the effect of the preparations is visually evaluated in comparison with untreated controls. For example, 100% activity = plant died, 0% activity = similar to the control plants.

[0259] The following tables B1 to B14 show the effect of selected compounds of general formula (I) according to table 1 on various harmful plants and application rates equivalent to up to 320 g / ha, obtained by the test procedures specified above. Appendices "a" and "b" give a distinction according to the application rates used on the same harmful plants tested.

[0260] [Table 4]

[0261] TIFF2024542693000073.tif255137

[0262] TIFF2024542693000074.tif255138

[0263] TIFF2024542693000075.tif255138

[0264] TIFF2024542693000076.tif255137

[0265] TIFF2024542693000077.tif254139

[0266] TIFF2024542693000078.tif254139

[0267] TIFF2024542693000079.tif255138

[0268] TIFF2024542693000080.tif255140

[0269] TIFF2024542693000081.tif240138

[0270] TIFF2024542693000082.tif254141

[0271] TIFF2024542693000083.tif255139

[0272] TIFF2024542693000084.tif254139

[0273] TIFF2024542693000085.tif255139

[0274] TIFF2024542693000086.tif254140

[0275] TIFF2024542693000087.tif255137

[0276] TIFF2024542693000088.tif255137

[0277] TIFF2024542693000089.tif254139

[0278] TIFF2024542693000090.tif255138

[0279] TIFF2024542693000091.tif80138

[0280] The following tables B15 to B19 represent the crop plant compatibility of selected compounds of general formula (I) according to table 1 at application rates corresponding to 320 g / ha or less, which were observed in tests according to the test procedures specified above. The observed effects on selected crop plants are reported here (values ​​in %), compared to untreated controls. Appendices "a", "b" and "c" give a distinction according to the application rates used on the same harmful plants tested. [Table 5]

[0281] TIFF2024542693000093.tif239137

[0282] TIFF2024542693000094.tif240138

[0283] TIFF2024542693000095.tif255137

[0284] TIFF2024542693000096.tif255139

[0285] TIFF2024542693000097.tif244140

[0286] TIFF2024542693000098.tif81141

[0287] As shown by the results from Tables B1 to B19, the compounds of general formula (I) of the present invention, in the case of post-emergence treatment, have an excellent activity against harmful plants, for example, Abutilon theophrasti (ABUTH), Alopecurus myosuroides (ALOMY), Amaranthus retroflexus (AMARE), Avena fatua (AVEFA), Digitaria sanguinalis (DIGSA), Echinochloa crus-galli (ECHCG), Bassia scoparia (KCHSC), Lolium rigidum (LOLRI), Matricaria inodora (MATIN), Pharbitis purpurea (PHBPU), Polygonum serrata (POLYGONUM serrata) ... It has good herbicidal effect against P. convolvulus (POLCO), Setaria viridis (SETVI), Veronica persica (VERPE) and Viola tricolor (VIOTR) at application rates of up to 320 g of active substance per hectare, and good crop-plant compatibility in the case of organisms such as rice (Oryza sativa) (ORYSA), corn (Zea mays) (ZEAMX), rapeseed (Brassica napus) (BRSNW), soybean (Glycine max) (GLXMA) and bread wheat (Triticum aestivum) (TRZAS) at application rates of up to 320 g per hectare.

[0288] The compounds of the invention are therefore suitable for controlling undesirable plant growth by post-emergence methods.

Claims

1. General formula (I) [Formula 1] [During the ceremony, A is selected from the group consisting of A1, A2 and A3; [chemical 2] Q is selected from the group consisting of Q1 to Q16; [C3] R 1 is OR 1a Or N.R. 9 R 10 and R 1a is hydrogen, or (C 1 -C 6 )-alkyl or (C 3 -C 6 )-cycloalkyl (which are unsubstituted or each independently COOR 5 , halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 6 )-substituted by "m" radicals selected from the group consisting of alkoxy, cyano and nitro; or (C 3 -C 4 )-alkenyl or (C 3 -C 4 )-alkynyl, or (C 1 -C 6 )-alkyl-S-(C 1 -C 6 )-alkyl-, (C 1 -C 6 )-alkyl-SO-(C 1 -C 6 )-alkyl- or (C 1 -C 6 )-Alkyl-SO 2 - (C 1 -C 6 )-alkyl-, or heterocyclyl, heteroaryl or aryl, or Heterocyclyl-(C 1 -C 4 )-alkyl-, heteroaryl-(C 1 -C 4 )-alkyl- or aryl-(C 1 -C 4 )-alkyl-(which are unsubstituted or each independently selected from halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl; R 9 is hydrogen or (C 1 -C 12 )-alkyl; R 10 is hydrogen, aryl, heteroaryl, heterocyclyl, (C 1 -C 12 )-alkyl, (C 3 -C 8 )-cycloalkyl, (C 3 -C 8 )-cycloalkyl-(C 1 -C 7 )-alkyl-, (C 2 -C 12 )-alkenyl, (C 5 -C 7 )-cycloalkenyl, (C 2 -C 12 )-alkynyl, S(O) n R 5 , Cyano, OR 5 , S.O. 2 N.R. 6 R 7 , CO 2 R 8 or C.O.R. 8wherein the above alkyl, cycloalkyl, alkenyl, cycloalkenyl and alkynyl radicals are unsubstituted or each independently may be mono- or polysubstituted aryl, halogen, cyano, nitro, OR 5 , S(O) n R 5 , S.O. 2 N.R. 6 R 7 , CO 2 R 8 , C.O.R. 6 R 8 , C.O.R. 6 , N.R. 6 R 8 , N.R. 6 C.O.R. 8 , N.R. 6 C.O.N.R. 8 R 8 , N.R. 6 CO 2 R 8 , N.R. 6 SO 2 R 8 , N.R. 6 SO 2 N.R. 6 R 8 , C(R 6 ) = NOR 8 and is substituted with "m" radicals selected from the group consisting of: or R 9 and R 10 together with the nitrogen atom to which they are attached, halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl, OR 5 , S(O) n R 5 , CO 2 R 8 , C.O.R. 6 R 8 , C.O.R. 6 and C(R 6 ) = NOR 8and, in addition to the nitrogen atom, the ring atoms include "r" carbon atoms, "o" oxygen atoms, "p" sulfur atoms, and NR 7 , CO and NCOR 7 forming a saturated or partially or fully unsaturated 5-, 6- or 7-membered ring containing "q" elements from the group consisting of: R 5 (C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 6 )-haloalkyl or aryl; R 6 is hydrogen, (C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 6 )-haloalkyl or aryl; R 7 is hydrogen, (C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 4 )-alkenyl or (C 3 -C 4 )-alkynyl, R 8 is hydrogen, (C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 4 )-alkenyl, (C 1 -C 6 )-alkyl-COO(C 1 -C 2 )-alkyl- or (C 3 -C 4 )-alkynyl, R 2 (C 1-C 4 )-alkylthio; R 3 is halogen, cyano, isocyano, nitro, (C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 6 )-haloalkyl, (C 3 -C 6 )-halocycloalkyl, (C 1 -C 6 )-alkylcarbonyl-, (C 1 -C 6 )-haloalkylcarbonyl-, (C 1 -C 6 )-alkyloxycarbonyl-, (C 2 -C 3 )-alkenyl, (C 2 -C 3 )-haloalkenyl, (C 2 -C 3 )-alkynyl, (C 2 -C 3 )-haloalkynyl, (C 1 -C 6 )-alkyl-S(O) n and (C 1 -C 6 )-haloalkyl-S(O) n , CHO and NH 2 and R 12 is halogen, cyano, nitro, (C 1 -C 6 )-alkyl or (C 1 -C 6 )-haloalkyl; R 13 is halogen, cyano, nitro, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl, (C 1 -C 6 )-alkylcarbonyl, (C 1 -C 6 )-haloalkylcarbonyl, (C 1 -C 6 )-alkoxycarbonyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-haloalkoxy, (C 1 -C 6 )-alkylS(O) n , (C 2 -C 3 )-alkenyl, (C 2 -C 3 )-haloalkenyl, (C 2 -C 3 )-alkynyl or (C 2 -C 3 )-haloalkynyl; h is 0, 1 or 2; i is 0, 1, 2 or 3; k is 0, 1, 2, 3 or 4; m is 0, 1, 2 or 3; n is 0, 1 or 2; o is 0, 1 or 2; p is 0 or 1; q is 0 or 1; r is 3, 4, 5 or 6; s is 0, 1, 2, 3, 4 or 5. and its derivatives, their agriculturally acceptable salts, N-oxides, hydrates, and hydrates of the salts and hydrates of the N-oxides thereof.

2. A is selected from A1-1, A1-2, A1-3, A1-4, A2-1, A3-1, A3-2, A3-3, A3-4 and A3-5; [C4] Q is selected from the group consisting of Q1, Q2, Q9 and Q16; [C5] R 1 But, OR 1a Or N.R. 9 R 10 and R 1a is hydrogen, or (C 1 -C 6 )-alkyl or (C 3 -C 6 )-cycloalkyl (which are unsubstituted or each independently COOR 5 , halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 6 )-substituted by "m" radicals selected from the group consisting of alkoxy, cyano and nitro; or (C 3 -C 4 )-alkenyl or (C 3 -C 4 )-alkynyl, or MeS-(C 2 -C 3 )-alkyl-, MeSO-(C 2 -C 3 )-alkyl, MeSO 2 - (C 2 -C 3 )-alkyl, aryl-(C 1 -C 2 )-alkyl-(wherein the aryl radicals are unsubstituted or each independently selected from halogen, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl; R 9 is hydrogen or (C 1 -C 4 )-alkyl; R 10 is hydrogen, phenyl, (C 1 -C 4 )-alkyl, (C 2 -C 4 )-alkenyl, (C 2 -C 4 )-alkynyl, S(O) n R 5 or S.O. 2 N.R. 6 R 7 wherein the above alkyl, alkenyl and alkynyl radicals are unsubstituted or each independently selected from halogen, cyano, S(O) n R 5 , CO 2 R 8 , C.O.R. 6 R 8 or R 9 and R 10 together with the nitrogen atom to which they are attached, (C 1 -C 4 )-alkyl, (C 1 -C 4 )-haloalkyl, CO 2 R 8 and C.O.N.R. 6 R 8 forming a saturated or partially or fully unsaturated 5-, 6- or 7-membered ring, which may be mono- or disubstituted by radicals from the group consisting of R 5 However, (C 1 -C 4 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 4 )-haloalkyl or phenyl; R 6 is hydrogen, (C 1 -C 4 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 4 )-haloalkyl or phenyl; R 7 is hydrogen, (C 1 -C 4)-alkyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 4 )-alkenyl or (C 3 -C 4 )-alkynyl, R 8 is hydrogen, (C 1 -C 4 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 4 )-alkenyl or (C 3 -C 4 )-alkynyl, R 2 However, (C 1 -C 3 )-alkylthio; R 3 is halogen, cyano, isocyano, nitro, (C 1 -C 4 )-alkyl, (C 3 -C 6 )-cycloalkyl, (C 1 -C 6 )-haloalkyl, (C 3 -C 6 )-halocycloalkyl, (C 2 -C 3 )-alkenyl, (C 2 -C 3 )-haloalkenyl, (C 2 -C 3 )-alkynyl or (C 2 -C 3 )-haloalkynyl; R 13 is halogen, cyano, nitro, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-haloalkoxy, (C 1 -C 6 )-alkylS(O) n , (C 2 -C 3 )-alkenyl, (C 2 -C 3 )-haloalkenyl, (C 2 -C 3 )-alkynyl or (C 2 -C 3 )-haloalkynyl; i is 0, 1 or 2; k is 0, 1, 2 or 3; m is 0, 1 or 2; n is 0, 1 or 2; s is 0, 1, 2, 3, 4 or 5 2. A compound of formula (I) according to claim 1, or a pesticidally acceptable salt, N-oxide, hydrate, or a hydrate of the salt or N-oxide thereof.

3. A is selected from A1-1, A1-2, A1-3, A1-4, A2-1, A3-1, A3-2, A3-3, A3-4 and A3-5; [C6] Q is selected from the group consisting of Q1, Q2, Q9 and Q16; [C7] R 1 But, OR 1a Or N.R. 9 R 10 and R 1a is hydrogen, or (C 1 -C 3 )-alkyl (which is unsubstituted or -C(O) 2 substituted with a substituent selected from the group consisting of cyclopropyl, ... (C 3 -C 6 )-cycloalkyl, or Phenyl-(C 1 -C 2)-alkyl-, which is unsubstituted or substituted with "m" radicals, each independently selected from the group consisting of fluorine, chlorine, bromine, methyl, trifluoromethyl; R 9 is hydrogen, R 10 However, (C 1 -C 4 )-alkyl (which is unsubstituted or CO 2 R 8 and R 8 is methyl or ethyl, R 2 is methylthio or ethylthio, R 3 is halogen, cyano, nitro, (C 1 -C 2 )-alkyl, (C 3 -C 5 )-cycloalkyl, (C 1 -C 2 )-haloalkyl, (C 3 -C 5 )-halocycloalkyl, (C 2 -C 3 )-alkenyl or (C 2 -C 3 )-alkynyl, R 13 Fluorine, chlorine, bromine, cyano, methyl, ethyl, methoxy, ethoxy, CF 3 or O.C.F. 3 and i is 0, 1 or 2; k is 0, 1 or 2; m is 0, 1 or 2; s is 0, 1 or 2 3. A compound of formula (I) according to claim 1 or 2, or a pesticidally acceptable salt, N-oxide, hydrate, or a hydrate of the salt or N-oxide thereof.

4. A is selected from the group consisting of A1-1, A1-2, A1-3, A1-4, A2-1, A3-1, A3-2, A3-3, A3-4 and A3-5; [C8] Q is selected from the group consisting of Q1, Q9 and Q16; [C9] R 1 But, OR 1a and R 1a is hydrogen, ethyl, methyl, MeOOC(Me)CHCH 2 - or MeOOCCH 2 CH 2 - and R 2 is methylthio or ethylthio, R 3 is fluorine, chlorine, bromine, iodine, cyano, nitro, cyclopropyl, 2,2-difluorocyclopropyl, ethenyl or CF 3 and R 13 is fluorine, chlorine, bromine, methyl or CF 3 and i is 0, 1 or 2; k is 0, 1 or 2; s is 0, 1 or 2 A compound of formula (I) according to any one of claims 1 to 3, or a pesticidally acceptable salt, N-oxide, hydrate, or a hydrate of the salt or N-oxide thereof.

5. A process for the preparation of a compound of formula (Ic) or a pesticide-acceptable salt thereof as defined in any of claims 1 to 4 by converting a compound of general formula (III) and (IV) in the presence of a sulfurizing reagent, such as phosphorus pentasulfide or Lawesson's reagent. [C10] [In the formula, R 2 , R 1a , R 3 , A, and Q have the above definitions, and X is chlorine, bromine, or iodine.

6. A process for the preparation of a compound of formula (Ia) or a pesticidally acceptable salt thereof according to any of claims 1 to 4, by converting a compound of general formula (Ic) in the presence of a base or a Lewis acid. [C11] [In the formula, R 2 , R 1a , R 3 , A and Q have the definitions given above.

7. A process for the preparation of a compound of formula (Ib) or a pesticidally acceptable salt thereof according to any of claims 1 to 4, by converting compounds of general formula (Ia) and (II) in the presence of a peptide coupling reagent. [C12] [In the formula, R 9 , R 10 , R 2 , R 1a , R 3 , A and Q have the definitions given above.

8. 1. An agrochemical composition comprising a) at least one compound of formula (I) as defined in one or more of claims 1 to 4 or a pesticidally acceptable salt thereof, and b) auxiliaries and additives customary in crop protection.

9. 1. A pesticide composition comprising: a) at least one compound of formula (I) as defined in any one or more of claims 1 to 4 or a pesticidally acceptable salt thereof, b) one or more active pesticide ingredients other than component a), and Optionally, c) auxiliaries and additives customary in crop protection.

1. A pesticide composition comprising:

10. A method for controlling undesirable vegetation or for regulating the growth of plants, which comprises applying to the plant, to a seed or to the area in which the plant is growing an effective amount of at least one compound of formula (I) as defined in one or more of claims 1 to 4 or a pesticidally acceptable salt thereof.

11. Use of a compound of formula (I) as defined in one or more of claims 1 to 4 or a pesticidally acceptable salt thereof as a herbicide or plant growth regulator.

12. 12. The use according to claim 11, wherein the compound of formula (I) or a pesticidally acceptable salt thereof is used for controlling or regulating the growth of harmful plants in crop plants.

13. The use according to claim 12, wherein the crop plant is a transgenic or non-transgenic crop plant.

Citation Information

Patent Citations

  • Pyrazoleoxy acetic acid compounds, preparation method and use

    CN101284815A

  • new 5-PHENYLPYRAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND MEDICINAL PRODUCTS

    DE2828529A1

  • JP5323-5330

  • In vitro methods for the induction and maintenance of plant cell lines as single suspension cells with intact cell walls, and transformation thereof

    WO2008083233A2

  • 1-phenyl-5-azinyl pyrazolyl-3-oxyalkyl acids and their use for controlling undesired plant growth

    WO2020245044A1